FedInvent™ Patent Applications

Application Details for Thursday, May 18, 2023 

This page was updated on Friday, May 26, 2023 at 02:43 AM GMT

Department of Health and Human Services (HHS) 

US 20230148587 CAMPBELL et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
APPLICANT(S) TISSUE TESTING TECHNOLOGIES LLC (North Charleston, South Carolina)
ASSIGNEE(S) TISSUE TESTING TECHNOLOGIES LLC (North Charleston, South Carolina)
INVENTOR(S) Lia H. CAMPBELL (Mount Pleasant, South Carolina);  Kelvin G.M. BROCKBANK (CHARLESTON, South Carolina)
ABSTRACT Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).
FILED Tuesday, November 15, 2022
APPL NO 17/987404
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0221 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230148852 Liang
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Arizona)
ASSIGNEE(S)
INVENTOR(S) Rongguang Liang (Tucson, Arizona)
ABSTRACT Systems, devices and methods for imaging hard-to-view and hard-to-reach places in the oral cavity, such as at the base of the tongue and tonsillar regions, are described. An example mobile intraoral imaging system includes a white light source and a blue or ultraviolet light source for illuminating a region in the oral cavity. The system includes a mobile device configured to receive information associated with reflected and autofluorescent light from the region in the oral cavity, as well as a semi-flexible probe that includes a bendable tip; the probe is changeable in shape to allow insertion in the oral cavity and includes a camera that is positioned at a section of its tip to capture the reflected and autofluorescent light. The system enables quick acquisition of high-quality images, and allows remote imaging and diagnosis of suspicious lesions in the oral cavity.
FILED Monday, April 05, 2021
APPL NO 17/995595
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 1/24 (20130101) Original (OR) Class
A61B 1/043 (20130101)
A61B 1/00096 (20130101)
A61B 1/0646 (20130101)
A61B 1/0661 (20130101)
A61B 5/0071 (20130101)
A61B 5/0088 (20130101)
A61B 5/7264 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230148909 Bijan
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) Baylor College of Medicine (Houston, Texas)
ASSIGNEE(S)
INVENTOR(S) Najafi Bijan (Houston, Texas)
ABSTRACT A system for patient activity monitoring may include a wearable device and a personal terminal. The personal terminal may include a processor. The processor of the personal terminal may be configured to receive, from the wearable device, proximity detection information specifying proximity detected by the wearable device between the wearable device and a tag device and sensor data received by the wearable device from the tag device. The processor of the personal terminal may be further configured to determine, based on the proximity detection information and the sensor data, that an action was performed by a patient.
FILED Tuesday, April 13, 2021
APPL NO 17/995540
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/746 (20130101)
A61B 5/1112 (20130101)
A61B 5/1113 (20130101) Original (OR) Class
A61B 5/4088 (20130101)
A61B 5/6801 (20130101)
A61B 2562/0219 (20130101)
A61B 2562/0257 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230148951 Thatcher et al.
FUNDED BY
Department of Defense (DOD)
Defense Health Agency (DHA)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) SPECTRAL MD, INC. (Dallas, Texas)
ASSIGNEE(S)
INVENTOR(S) Jeffrey E. Thatcher (Irving, Texas);  Wensheng Fan (Plano, Texas);  Kevin Plant (Richardson, Texas);  Faliu Yi (Allen, Texas)
ABSTRACT The present disclosure relates to systems and methods for assessing or predicting the status of wounds such as burns. Systems can include at least one light detection element and one or more processors configured to receive a signal from the at least one light detection element representing light reflected from a tissue region, generate an image having a plurality of pixels depicting the tissue region, and determine a burn status of a subset of pixels of the image using one or more deep learning algorithms. Systems can further be configured to generate a classified image of the tissue region and/or determine a predictive score associated with healing of the wound.
FILED Tuesday, January 10, 2023
APPL NO 18/152654
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0075 (20130101)
A61B 5/445 (20130101) Original (OR) Class
A61B 5/4842 (20130101)
A61B 5/7267 (20130101)
A61B 5/7275 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 2207/20084 (20130101)
G06T 2207/30088 (20130101)
G06T 2207/30101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149000 MILNER et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
ASSIGNEE(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Thomas E. MILNER (Austin, Texas);  Jason B. KING (Austin, Texas);  Nitesh KATTA (Austin, Texas);  James W. TUNNELL (Austin, Texas)
ABSTRACT Apparatus and methods for tissue excision. In certain aspects, the apparatus and methods include an annular converging laser beam. The annular converging laser beam can be directed to a surface of a tissue and displace a portion of the tissue in a single or multiple laser pulses. In particular aspects, the dosimetry of the laser beam (e.g. the beam shape, pulse energy and pulse duration) can be controlled to eject the portion of the tissue in a manner to reduce damage to the displaced tissue and the surrounding tissue.
FILED Friday, April 09, 2021
APPL NO 17/995865
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 10/02 (20130101) Original (OR) Class
A61B 18/22 (20130101)
A61B 2018/00761 (20130101)
A61B 2018/2205 (20130101)
A61B 2018/2266 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149089 TRAYANOVA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
INVENTOR(S) Natalia A. TRAYANOVA (Baltimore, Maryland);  Eric SUNG (Baltimore, Maryland);  Adityo PRAKOSA (Baltimore, Maryland);  Shijie ZHOU (Baltimore, Maryland)
ABSTRACT A method for guiding ablation of atrial or ventricular arrhythmia in a patient's heart is provided. A digital representation of the electrical functioning of atria or ventricles of the patient's heart is generated based on imaging data of the patient's heart that reveals the presence of adipose tissue. The arrhythmias arising in the presence of the adipose tissue in the digital representation of the patients atria or ventricles are determined. The method further includes identifying, in the digital representation, ablation targets that need to be ablated to terminate determined arrhythmias; executing, in the digital representation, a mock-up of a clinical ablation procedure of the patient to determine the electrical response of the patients heart to ablating the ablation targets, and to determine whether the heart continues to generate new arrhythmias post-procedure; and generating a final set of ablation targets based on the mock-up of the clinical ablation procedure.
FILED Tuesday, April 06, 2021
APPL NO 17/995148
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 18/1477 (20130101)
A61B 34/10 (20160201) Original (OR) Class
A61B 2018/00577 (20130101)
A61B 2034/104 (20160201)
A61B 2034/105 (20160201)
A61B 2034/107 (20160201)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 20/40 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149216 Knox et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) University of Rochester (Rochester, New York)
ASSIGNEE(S)
INVENTOR(S) Wayne Knox (Rochester, New York);  Jonathan D. Ellis (Tucson, Arizona);  Krystel R. Huxlin (Rush, New York);  Daniel R. Brooks (Rochester, New York);  Kaitlin T. Wozniak (Rochester, New York)
ABSTRACT Refractive index writing system and methods employing a pulsed laser source for providing a pulsed laser output at a first wavelength; an objective lens for focusing the pulsed laser output to a focal spot in an optical material; a scanner for relatively moving the focal spot with respect to the optical material at a relative speed and direction along a scan region for writing one or more traces in the optical material defined by a change in refractive index; and a controller for controlling laser exposures along the one or more traces in accordance with a calibration function for the optical material to achieve a desired refractive index profile in the optical material. The refractive index writing system may be for writing traces in in vivo optical tissue, and the controller may be configured with a calibration function obtained by calibrating refractive index change induced in enucleated ocular globes. A real-time process control monitor for detecting emissions from the optical material transmitted through the objective lens at a second wavelength may further be employed while writing the one or more traces.
FILED Friday, January 20, 2023
APPL NO 18/099402
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 9/00804 (20130101)
A61F 9/00827 (20130101) Original (OR) Class
A61F 2009/00855 (20130101)
A61F 2009/00897 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149295 McKEON et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Houston System (Houston, Texas);  The Board of Regents of The University of Texas System (Austin, Texas);  Tract Pharmaceuticals, Inc. (West Hartford, Connecticut)
ASSIGNEE(S) University of Houston System (Houston, Texas);  The Board of Regents of The University of Texas System (Austin, Texas);  Tract Pharmaceuticals, Inc. (West Hartford, Connecticut)
INVENTOR(S) Frank McKEON (Houston, Texas);  Rahul NEUPANE (Houston, Texas);  Jingzhong XIE (Houston, Texas);  Wa XIAN (Houston, Texas);  Matthew VINCENT (West Hartford, Connecticut);  Shan WANG (Houston, Texas)
ABSTRACT The present disclosure addresses IBD from the standpoint of inhibiting or ablating pathogenic mucosal stem cells cloned from defined regions of disease in the gastrointestinal tract. In the case of Crohn's disease, for example, isolation of those stem cells according to the methods of the present disclosure reveals a pattern of inflammatory gene expression in stem cells from the terminal ileum and colon that is epigenetically maintained despite months of continuous cultivation in the absence of immune or stromal cells, or of intestinal microbes. Superimposed on this distributed inflammatory phenotype is a differentiation defect that profoundly and specifically alters the mucosal barrier properties of the terminal ileum. The co-existence of diseased and normal stem cells within the same endoscopic biopsies of Crohn's disease patients implicates an epigenetically enforced heterogeneity among mucosal stem cells in the dynamics of this condition.
FILED Tuesday, March 09, 2021
APPL NO 17/906027
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 47/34 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149307 BAO et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (Montréal, Canada)
ASSIGNEE(S)
INVENTOR(S) Guangyu BAO (Montréal, Canada);  Jianyu LI (Verdun, Canada);  Luc MONGEAU (Mont Royal, Canada);  Sareh TAHERI (Montréal, Canada);  Sepideh MOHAMMADI (Montréal, Canada)
ABSTRACT There is provided a porous double-network hydrogel comprising: a first network comprising a first polymer; a second network comprising a second polymer. The porous double-network hydrogel comprises pores having a diameter of at least 1 μm, and the porous double-network hydrogel is perfusable and injectable.
FILED Thursday, November 10, 2022
APPL NO 18/054292
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/06 (20130101) Original (OR) Class
A61K 9/0019 (20130101)
A61K 35/36 (20130101)
A61K 47/32 (20130101)
A61K 47/36 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 7/04 (20180101)
A61P 17/02 (20180101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 3/075 (20130101)
C08J 2305/08 (20130101)
C08J 2333/26 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149319 Morris et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) City of Hope (Duarte, California)
ASSIGNEE(S)
INVENTOR(S) Kevin Morris (Duarte, California);  Tristan Scott (Duarte, California)
ABSTRACT Provided herein are, inter alia, recombinant fusion proteins and exosomes comprising recombinant fusion proteins; wherein the recombinant fusion proteins comprises exosome membrane-associated proteins and exogenous target proteins; pharmaceutical compositions; and methods of using the recombinant fusion proteins, exosomes, and pharmaceutical compositions to treat diseases such as cancer, HIV, and COVID-19.
FILED Monday, April 12, 2021
APPL NO 17/912450
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/5184 (20130101) Original (OR) Class

Peptides
C07K 16/1063 (20130101)
C07K 2317/622 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149321 Du et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) DuPage Medical Technology, Inc. (Chicago, Illinois)
ASSIGNEE(S)
INVENTOR(S) Xiaoping Du (Chicago, Illinois);  Ying Liu (Clarendon Hills, Illinois)
ABSTRACT Provided herein is a method of producing peptide nanoparticles comprising vortex-mixing (a) a hydrophobic or amphiphilic peptide or peptide conjugate, (b) one or more lipids that are free of a water-soluble polymer, (c) one or more lipids covalently attached to a water-soluble polymer, and (d) a hydrophilic solvent, to provide peptide nanoparticles.
FILED Monday, March 01, 2021
APPL NO 17/802917
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/19 (20130101)
A61K 9/5123 (20130101)
A61K 9/5146 (20130101)
A61K 9/5192 (20130101) Original (OR) Class
A61K 38/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149327 Marchant et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Medical College of Wisconsin, Inc. (Milwaukee, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) Jonathan Stephen Marchant (Brookfield, Wisconsin);  Tom Paul Aufderheide (Wauwatosa, Wisconsin)
ABSTRACT Described herein are methods for treating COVID-19 or preventing COVID-19 in a subject exposed to SARS-CoV-2 by administering to the subject a therapeutically effective amount of salmeterol or the pharmaceutically acceptable salt thereof.
FILED Wednesday, April 21, 2021
APPL NO 17/920611
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/137 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149338 SIMPSON et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Sierra SIMPSON (San Diego, California);  Olivier GEORGE (Lemon Grove, California)
ABSTRACT The present disclosure provides a novel treatment for addiction disorders, particularly opioid addiction. More specifically, the present disclosure provides a treatment for opioid addiction comprising a combination use of any one or more of SCFAs in combination with one or more carnitines, providing effective depletion of microbiome in certain brain regions. A diagnosis method for the progress of the addiction treatment is also provided.
FILED Tuesday, April 13, 2021
APPL NO 17/916610
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/19 (20130101)
A61K 31/205 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/36 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149358 GIUS et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Galera Labs, LLC (Malvem, Pennsylvania);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) David R. GIUS (Chicago, Illinois);  Robert A. BEARDSLEY (University City, Missouri);  Yueming ZHU (Chicago, Illinois);  Jon HOLMLUND (Carlsbad, California);  Jeffery L. KEENE (St. Louis, Missouri)
ABSTRACT A method of treating a cancer in a mammalian subject with a tumor signature characterized by any one or more of (i) a level of sirtuin (SIRT3) protein that is below a first predetermined threshold level, (ii) a level of manganese superoxide dismutase acetylated at the lysine 68 residue (AcK68) that exceeds a second predetermined threshold level, and (iii) expression levels of hypoxia-inducible factor 2α (HIF2α) that exceed a third predetermined threshold level indicative of lineage plasticity for stemness, the method comprising administering to the mammalian subject a therapeutically effective amount of a pentaaza macrocyclic ring complex corresponding to the Formula (I) below, optionally with administration of a further anti-cancer therapeutic agent.
FILED Wednesday, November 30, 2022
APPL NO 18/071724
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4166 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0089 (20130101)

Enzymes
C12Y 115/01001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149403 Siracusa
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Rutgers, the State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) Rutgers, the State University of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Mark C. Siracusa (New Brunswick, New Jersey)
ABSTRACT The invention provides methods and compositions that are useful for treating allergic diseases, bacterial infections, fungal infections, viral infections, mastocytosis, mast cell-mediated inflammation and parasite infections (e.g., helminth infections).
FILED Thursday, June 30, 2022
APPL NO 17/855501
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/18 (20130101)
A61K 31/423 (20130101)
A61K 31/433 (20130101)
A61K 31/451 (20130101)
A61K 31/505 (20130101)
A61K 31/513 (20130101) Original (OR) Class
A61K 31/542 (20130101)
A61K 31/4184 (20130101)
A61K 31/7048 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 11/06 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149442 Wagner et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) William R. Wagner (Gibsonia, Pennsylvania);  Yasumoto Matsumura (Pittsburgh, Pennsylvania);  Murugesan Velayutham (Pittsburgh, Pennsylvania);  Yang Zhu (Pittsburgh, Pennsylvania)
ABSTRACT Provided herein are antioxidant, thermally-responsive polymeric compositions and methods of making and using the compositions, e.g., for treatment of ischemia reperfusion injury or radiation exposure.
FILED Wednesday, January 18, 2023
APPL NO 18/098473
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0024 (20130101)
A61K 31/79 (20130101) Original (OR) Class

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 31/145 (20130101)
A61L 2400/06 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 220/54 (20130101)
C08F 290/061 (20130101)
C08F 299/045 (20130101)
C08F 2438/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149460 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Jianzhu Chen (Lexington, Massachusetts);  Jerome Ritz (Lincoln, Massachusetts);  Rizwan Romee (Wellesley, Massachusetts);  Han Dong (Boston, Massachusetts);  Guozhu Xie (Cambridge, Massachusetts);  James Dongjoo Ham (Cambridge, Massachusetts)
ABSTRACT The present disclosure relates to cytokine-induced memory-like NK cells expressing a chimeric antigen receptor polypeptide that binds to a neoepitope of mutant nucleophosmin (NPM1c) in complex with, or presented by, a class I major histocompatibility complex (MHC class I) protein, or cells expressing such compounds, and their use in methods for treating, or ameliorating one or more symptoms of, cancer.
FILED Wednesday, March 10, 2021
APPL NO 17/910776
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Peptides
C07K 16/2818 (20130101)
C07K 16/3061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149467 MONTGOMERY et al.
FUNDED BY
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) Cellphire, Inc. (Rockville, Maryland)
ASSIGNEE(S) Cellphire, Inc. (Rockville, Maryland)
INVENTOR(S) Joshua Donald MONTGOMERY (Silver Spring, Maryland);  Braden Carl ISHLER (Montgomery Village, Maryland);  Stephen Edward AMOS (Buckeystown, Maryland);  Keith Andrew MOSKOWITZ (Westfield, Indiana);  Amber Nicole LEE (Montgomery Village, Maryland);  Rafael JORDA (Merignac, France);  Glen Michael FITZPATRICK (North Potomac, Maryland);  Michael Alexander MATHEWS (Arlington, Virginia)
ABSTRACT Provided herein are materials and methods for the preparation of blood products. In some aspects, provided herein are compositions that include populations of platelet derivatives, including freeze-dried platelet derivatives, methods of producing the same, as well as methods of using the same to treat a subject. Such platelet derivatives have improved properties, as disclosed herein.
FILED Friday, November 04, 2022
APPL NO 18/052709
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/19 (20130101)
A61K 35/19 (20130101) Original (OR) Class
A61K 47/26 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149469 Frank et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The United States Government as represented by The Department of Veterans Affairs (Washington, District of Columbia);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) The United States Government as represented by The Department of Veterans Affairs (Washington, District of Columbia);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Children's Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) Markus H. Frank (Cambridge, Massachusetts);  Natasha Y. Frank (Cambridge, Massachusetts);  Dennis P. Orgill (Belmont, Massachusetts);  George F. Murphy (Boston, Massachusetts)
ABSTRACT The present invention is directed to wound healing scaffolds cografted with a population of stem cells, wherein the population of stem cells are ABCB5+ stem cells. The scaffolds are, for instance, collagen glycosaminoglycan scaffolds.
FILED Monday, September 19, 2022
APPL NO 17/947360
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101) Original (OR) Class
A61K 38/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/3834 (20130101)
A61L 27/3886 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/063 (20130101)
C12N 5/0668 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149501 Szeto
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Cornell Research Foundation, Inc. (New York, New York)
ASSIGNEE(S) Cornell Research Foundation, Inc. (New York, New York)
INVENTOR(S) Hazel H. Szeto (New York, New York)
ABSTRACT The invention provides a method for reducing oxidative damage in a mammal, a removed organ, or a cell in need thereof. The method comprises administering an effective amount of an aromatic cationic peptide. The aromatic cationic peptide has (a) at least one net positive charge; (b) a minimum of three amino acids; (c) a maximum of about twenty amino acids, (d) a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; (e) a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 3a or 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1; and (f) at least one tyrosine or tryptophan amino acid.
FILED Monday, October 04, 2021
APPL NO 17/493551
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/07 (20130101) Original (OR) Class
A61K 38/08 (20130101)
A61K 38/10 (20130101)

Peptides
C07K 5/1019 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149503 Deb
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of the University of California (Los Angeles, California)
ASSIGNEE(S)
INVENTOR(S) Arjun Deb (Los Angeles, California)
ABSTRACT The present disclosure relates to compositions and methods for treating a dysregulated wound healing, for improving wound healing, for inhibiting scar formation, for treating a subject with Ehlers Danlos syndrome (EDS), and for treating a subject diagnosed with a heart attack. The present disclosure further relates to compositions and methods for predicting future cardiac risk in a subject who has suffered a heart attack, and predicting risk of future cardiac disease in a subject suffering a heart attack.
FILED Wednesday, March 31, 2021
APPL NO 17/916337
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/12 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 17/02 (20180101)
A61P 19/04 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149518 Sauer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Research Foundation for The State University of New York (Binghamton, New York)
ASSIGNEE(S)
INVENTOR(S) Karin Sauer (Binghamton, New York);  Amber L. Doiron (Vestal, New York)
ABSTRACT A method of treating a biofilm on a surface, comprising: providing a surface having a biofilm; and administering to the surface a treatment that reduces a concentration of pyruvate of the biofilm, comprising pyruvate produced by at least a portion the biofilm, under conditions effective reducing maintenance of the biofilm on the surface. A composition, comprising purified enzyme, within a particle, effective for reducing pyruvate concentration in an aqueous suspension of the composition.
FILED Monday, January 02, 2023
APPL NO 18/092429
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 37/18 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/44 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Indexing Scheme Associated With Subclasses C12C - C12Q, Relating to Microorganisms
C12R 2001/38 (20210501)

Enzymes
C12Y 102/04001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149552 Koehler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  Universität Zürich (Zürich, Switzerland)
ASSIGNEE(S)
INVENTOR(S) Angela Nicole Koehler (Belmont, Massachusetts);  Shelby Doyle (Cambridge, Massachusetts);  Becky Leifer (Malden, Massachusetts);  Matthew Henley (Brighton, Massachusetts);  Beat W. Schaefer (Zürich, Switzerland);  Marco Wachtel (Zürich, Switzerland)
ABSTRACT The present disclosure provides compounds having the general formula P-L-U, or pharmaceutically acceptable salts thereof, wherein P is a FOXO1 fusion protein binding moiety, L is a bivalent linker, and U is an ubiquitin ligase binding moiety. Also provided are pharmaceutical compositions containing such compounds and methods of using such compounds.
FILED Friday, September 16, 2022
APPL NO 17/946898
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/55 (20170801) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149554 Disney
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
INVENTOR(S) Matthew D. Disney (Jupiter, Florida)
ABSTRACT Embodiments of methods are disclosed for inhibiting, regulating and/or otherwise affecting or managing the pri-miR-17-92 cluster, and certain pre-miRNA's embedded in the cluster as well as the pre-miRNA's themselves as isolated forms, as members of a library, present in oncogenic and/or polycystic cell lines and/or that are present in breast cancer, prostate cancer and/or polycystic kidney disease in animals or humans, or present in any other disease in which the pri-miR-17-92 cluster and the certain pre-miRNAs within in it cause or contribute to disease. The methods utilize compounds that target the structural feature or features of the pri-miR-17-92 cluster and/or the certain pre-miRNA's. The pre-miRNA's are members of the pre-miRNA-X group which includes one or more of pre-miR-17, pre-miR-18a, pre-miR-19a, pre-miR-19b-1, pre-miR-20a, and pre-miR-92a-1 or any combination thereof. The compounds incorporate a dimeric formula of a binding moiety for the certain pre-miRNA-X's. The binding moiety can bind or complex with structural feature(s) of the certain pre-miRNA-X's without specificity for the particular nucleotide sequence of the structural features. The binding moiety nevertheless is selective for the certain structural feature(s) so that it does not bind with other pre-miRNA's not having the certain structural feature(s).
FILED Wednesday, March 24, 2021
APPL NO 17/915985
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/22 (20130101)
A61K 47/64 (20170801) Original (OR) Class
A61K 47/549 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 13/08 (20180101)
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149656 Hall et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Third Pole, Inc. (Waltham, Massachusetts)
ASSIGNEE(S) Third Pole, Inc. (Waltham, Massachusetts)
INVENTOR(S) Gregory W. Hall (Belmont, Massachusetts);  Ian J. Gillerman (Somerville, Massachusetts);  Sina Mohsenian (Billerica, Massachusetts);  Aubrey Ortiz (Boston, Massachusetts);  Christopher Miles (Acton, Massachusetts);  Wolfgang Scholz (Beverly, Massachusetts);  Adam J. Young (Dedham, Massachusetts);  Benjamin Apollonio (Lunenburg, Massachusetts);  Ziad F. Elghazzawi (Newton, Massachusetts)
ABSTRACT Systems and methods for nitric oxide (NO) generation systems are provided. In some embodiments, an NO generation system comprises at least one pair of electrodes configured to generate a product gas containing NO from a flow of a reactant gas. The electrodes have elongated surfaces such that a plasma produced is carried by the flow of the reactant gas and glides along the elongated surfaces from a first end towards a second end of the electrode pair. A controller is configured to regulate the amount of NO in the product gas by the at least one pair of electrodes using one or more parameters as an input to the controller. The one or more parameters include information from a plurality of sensors configured to collect information relating to at least one of the reactant gas, the product gas, and a medical gas into which the product gas flows.
FILED Monday, October 24, 2022
APPL NO 18/049013
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 33/00 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 16/12 (20130101) Original (OR) Class
A61M 16/024 (20170801)
A61M 2202/0275 (20130101)
A61M 2205/33 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149745 KONOFAGOU et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
APPLICANT(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) Elisa E. KONOFAGOU (New York, New York);  Gesthimani Samiotaki (New York, New York)
ABSTRACT Methods and systems for modulation and mapping of brain tissue in a subject using an ultrasound assembly are provided. An exemplary method for modulation uses an ultrasound assembly including a housing and an ultrasound transducer joined to the housing. The method includes securing the housing to the head of the subject with the ultrasound transducer aligned with a region of the brain tissue to target the region of the brain tissue for modulating, and providing focused ultrasound at an acoustic pressure to the targeted region using the ultrasound transducer to induce cavitation proximate the targeted region. The method further includes detecting a cavitation signal magnitude from the induced cavitation corresponding to the acoustic pressure and modulating the targeted region.
FILED Friday, January 06, 2023
APPL NO 18/151052
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/13 (20130101)
A61B 8/42 (20130101)
A61B 8/481 (20130101)
A61B 8/0808 (20130101)
A61B 8/4254 (20130101)
A61B 8/4427 (20130101)
A61B 8/4477 (20130101)
A61B 8/5261 (20130101)
A61B 8/5269 (20130101)
A61B 17/225 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 7/00 (20130101) Original (OR) Class
A61N 2007/0065 (20130101)
A61N 2007/0095 (20130101)

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/52041 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149919 CAMPBELL et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
APPLICANT(S) TISSUE TESTING TECHNOLOGIES LLC (North Charleston, South Carolina)
ASSIGNEE(S) TISSUE TESTING TECHNOLOGIES LLC (North Charleston, South Carolina)
INVENTOR(S) Lia H. CAMPBELL (Mount Pleasant, South Carolina);  Gregory J. WRIGHT (HOT SPRINGS, North Carolina);  Elizabeth GREENE (MONCKS CORNER, South Carolina);  Kelvin G.M. BROCKBANK (CHARLESTON, South Carolina)
ABSTRACT Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.
FILED Tuesday, November 15, 2022
APPL NO 17/987257
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502 (20130101) Original (OR) Class
B01L 3/523 (20130101)
B01L 3/5085 (20130101)
B01L 9/543 (20130101)
B01L 2200/026 (20130101)
B01L 2300/0609 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0829 (20130101)
B01L 2300/0858 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149929 WANG et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Newomics Inc. (Berkeley, California)
ASSIGNEE(S)
INVENTOR(S) Daojing WANG (Moraga, California);  Po Ying YEH (Pleasanton, California)
ABSTRACT Disclosed herein are devices, methods, and systems for separating one or more biological particles from a fluid sample. The devices may comprise a substrate with a fluidic channel disposed therein. The fluidic channel has disposed therein an array of obstacles with a vertical spacing. The vertical spacing may be configured to separate one or more particles from a fluid stream when the stream flows through the fluidic channel. The devices, methods, and systems may be able to separate various types of biological particles at a high efficiency, sensitivity, and/or specificity.
FILED Friday, September 16, 2022
APPL NO 17/946892
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502753 (20130101)
B01L 3/502761 (20130101) Original (OR) Class
B01L 2200/0652 (20130101)
B01L 2300/0816 (20130101)
B01L 2400/086 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150922 Brugarolas et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Pedro Brugarolas (Ithaca, New York);  YuPeng Zhou (East Boston, Massachusetts)
ABSTRACT Described herein are fluorinated derivatives of gabapentin and methods of synthesis and methods of use thereof, e.g., in imaging and therapy.
FILED Wednesday, April 21, 2021
APPL NO 17/919848
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 51/0402 (20130101)
A61K 51/0446 (20130101)

General Methods of Organic Chemistry; Apparatus Therefor
C07B 39/00 (20130101)
C07B 59/001 (20130101)
C07B 59/002 (20130101)
C07B 2200/05 (20130101)

Acyclic or Carbocyclic Compounds
C07C 229/32 (20130101) Original (OR) Class
C07C 235/14 (20130101)

Heterocyclic Compounds
C07D 209/54 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150933 Chang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Kansas State University Research Foundation (Manhattan, Kansas);  Wichita State University (Wichita, Kansas);  University of Iowa Research Foundation (Iowa City, Iowa)
ASSIGNEE(S)
INVENTOR(S) Kyeong-Ok Chang (Manhattan, Kansas);  Yunjeong Kim (Manhattan, Kansas);  William C. Groutas (Wichita, Kansas);  Stanley Perlman (Iowa City, Iowa)
ABSTRACT Compounds exhibiting antiviral activity and/or inhibition of viral replication against viruses, particularly those belonging to the picornavirus-like supercluster, including coronavirus having a formula: (I) where X comprises a cyclic moiety, R2 is a branched or unbranched alkyl, cycloalkyl, aryl, arylalkyl, alkenyl, alkynyl, amino acid side chain, bicyclic or tricyclic side chain, combinations, and substituted forms thereof, and Z is selected from the group consisting of C1-C6 hydroxyalkyl, aldehydes, alpha-ketoamides, and bisulfite salts, and in particular —CH2OH, —CHO, —CH(0H)S03Na+, and -[0(C=0)Rw]S03Na+.
FILED Tuesday, March 30, 2021
APPL NO 17/907745
CURRENT CPC
Heterocyclic Compounds
C07D 207/26 (20130101) Original (OR) Class
C07D 405/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150935 Kwon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Ohyun Kwon (Los Angeles, California);  Changmin Xie (Los Angeles, California);  Jiannan Zhao (Los Angeles, California);  Nathan John Dupper (Los Angeles, California);  Aslam Shaikh (Los Angeles, California);  Jau-Nian Chen (Los Angeles, California);  Adam Langenbacher (Los Angeles, California)
ABSTRACT The present disclosure relates to compounds that are capable of modulating calcium ion homeostasis and treating disorders related thereto. The disclosure further relates to methods of making the aforementioned compounds.
FILED Friday, February 12, 2021
APPL NO 17/799521
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 9/06 (20180101)

Heterocyclic Compounds
C07D 207/48 (20130101) Original (OR) Class
C07D 401/04 (20130101)
C07D 405/04 (20130101)
C07D 409/04 (20130101)
C07D 413/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150943 Goodson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Boyd M. Goodson (Carbondale, Illinois);  Eduard Y. Chekmenev (Troy, Michigan);  Bryce E. Kidd (Carbondale, Illinois);  Jamil A. Mashni (Carbondale, Illinois);  Miranda Limbach (Creal Springs, Illinois);  Yuqing Hou (Carbondale, Illinois);  Fan Shi (Houston, Texas)
ABSTRACT The present disclosure is directed to a cleavable agent for enhanced magnetic resonance generally corresponding to the formula Y-L-R, wherein Y represents a catalyst-binding moiety having at least one isotopically labeled heteroatom, L represents a cleavable bond, and R represents a hyperpolarized payload having at least one isotopically labeled carbon. Also disclosed herein is a method of cleaving the cleavable agent for enhanced magnetic resonance.
FILED Wednesday, January 04, 2023
APPL NO 18/149740
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/12 (20130101)
B01J 2531/827 (20130101)

Heterocyclic Compounds
C07D 213/46 (20130101)
C07D 213/63 (20130101)
C07D 233/60 (20130101) Original (OR) Class
C07D 241/12 (20130101)
C07D 401/06 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/6506 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
G01R 33/282 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150948 Betts et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) H. LEE MOFFITT CONCERT CENTER AND RESEARCH INSTITUTE, INC. (Tampa, Florida)
ASSIGNEE(S)
INVENTOR(S) Brian Betts (Tampa, Florida);  Said M. Sebti (Tampa, Florida);  Harshani Lawrence (Tampa, Florida);  Nicholas Lawrence (Tampa, Florida);  Claudio Anasetti (Tampa, Florida);  Joseph Pidala (Tampa, Florida)
ABSTRACT Disclosed herein are compounds and methods for reducing the risk of developing, preventing, or treating graft versus host disease (GVHD) in a subject. The compounds can concurrently block Aurora kinase A and JAK2 signal transduction which synergistically suppresses alloreactive human T-cells in vitro, prevents xenogeneic graft-versus-host disease without impairing anti-tumor responses, and promotes the development and suppressive potency of CD39+ inducible Treg. In certain aspects, disclosed are compounds of Formula I-V.
FILED Thursday, January 19, 2023
APPL NO 18/098990
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/505 (20130101)
A61K 31/506 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Heterocyclic Compounds
C07D 239/48 (20130101) Original (OR) Class
C07D 401/12 (20130101)
C07D 403/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150960 Nevler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Thomas Jefferson University (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Avinoam Nevler (Narberth, Pennsylvania);  Christopher William Schultz (Riverton, New Jersey);  Jonathan Robert Brody (Philadelphia, Pennsylvania)
ABSTRACT Described herein are compounds of Formula I and methods of using said compounds for treating, ameliorating, and/or preventing cancer. The compounds are cyanine dyes, and have increased effects in hypoglycemic environments.
FILED Friday, January 29, 2021
APPL NO 17/796570
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/423 (20130101)
A61K 31/428 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 263/56 (20130101)
C07D 277/64 (20130101) Original (OR) Class

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 5/20 (20190201)
G16B 25/10 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150990 Tu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S)
INVENTOR(S) Zhude Tu (St. Louis, Missouri);  Vijai Kumar Reddy Tangadanchu (St. Louis, Missouri);  Hao Jiang (St. Louis, Missouri);  Buck Rogers (St. Louis, Missouri)
ABSTRACT Among the various aspects of the present disclosure is the provision of SphK inhibitors and methods of making and using same. An aspect of the present disclosure provides for an SphK2 inhibiting agent, wherein the SphK2 inhibiting agent is a 1,2,3-triazole having SphK2 inhibiting activity and SphK2 selectivity.
FILED Tuesday, August 16, 2022
APPL NO 17/820137
CURRENT CPC
Heterocyclic Compounds
C07D 413/10 (20130101)
C07D 413/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151021 Robertson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania);  BARUCH S. BLUMBERG INSTITUTE (Doylestown, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Erle S. Robertson (Wynnewood, Pennsylvania);  Yonggang Pei (Philadelphia, Pennsylvania);  Yanming Du (Cheshire, Connecticut)
ABSTRACT The present disclosure relates, in part, to certain compounds comprising brusatol derivatives, or a pharmaceutically acceptable salt, solvate, or polymorph thereof, which are useful for the treatment of hematological malignancies, including but not limited to leukemia and lymphoma. In certain embodiments, the present disclosure relates to pharmaceutical compositions of the compounds of the present disclosure.
FILED Tuesday, April 27, 2021
APPL NO 17/920663
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/02 (20180101)

Heterocyclic Compounds
C07D 493/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151029 Reddy et al.
FUNDED BY
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) QPEX BIOPHARMA, INC. (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Raja K. Reddy (San Diego, California);  David C. Griffith (San Marcos, California);  Emily Rigsbee (West Lafayette, Indiana);  Serge Henri Boyer (San Diego, California);  Scott J. Hecker (Del Mar, California);  Matthew Jonathan Jones (Linz, Austria)
ABSTRACT Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs). The boronic acid derivatives disclosed herein can be used in combination with various antibiotics to treat resistant bacteria.
FILED Wednesday, March 17, 2021
APPL NO 17/906340
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)

General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/13 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/025 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151052 REDDY
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE TEXAS A&M UNIVERSITY SYSTEM (COLLEGE STATION, Texas)
ASSIGNEE(S)
INVENTOR(S) DOODIPALA SAMBA REDDY (BRYAN, Texas)
ABSTRACT Described herein is the chemical structure of neurosteroid derivative compounds, methods of synthesizing the derivatives, and their uses in treating disorders, including those of the central nervous system. These compounds are readily synthesized and have improved pharmaceutical properties, including water solubility, compared to known neurosteroids.
FILED Friday, December 30, 2022
APPL NO 18/091431
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/08 (20180101)

Steroids
C07J 5/0015 (20130101)
C07J 41/0088 (20130101)
C07J 43/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151053 Micalizio
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Trustees of Dartmouth College (Hanover, New Hampshire)
ASSIGNEE(S)
INVENTOR(S) Glenn C. Micalizio (Norwich, Vermont)
ABSTRACT The present disclosure relates to stereodefined polycyclic (e.g., tetracyclic) compounds that contain quaternary centers at one or multiple ring fusions, synthetic methods for preparing such compounds, and methods of using such compounds to treat a disease, such as a brain tumor and, particularly, a glioma.
FILED Friday, October 28, 2022
APPL NO 18/050730
CURRENT CPC
Steroids
C07J 1/0055 (20130101)
C07J 75/005 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151058 KRISHNA et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) REALTA HOLDINGS, LLC (Norfolk, Virginia)
ASSIGNEE(S) REALTA HOLDINGS, LLC (Norfolk, Virginia)
INVENTOR(S) Neel K. KRISHNA (Norfolk, Virginia);  Kenji CUNNION (Norfolk, Virginia)
ABSTRACT The present invention provides peptide compounds that regulate the complement system and methods of using these compounds. The invention is an isolated, purified peptide of 30 amino acids derived from human astrovirus protein, called CP1. The invention is directed to peptide compounds that are peptide mimetics, peptide analogs and/or synthetic derivatives of CP1 having, for example, internal peptide deletions and substitutions, deletions and substitutions at the N-terminus and C-terminus, and that are able to regulate complement activation. The invention further provides pharmaceutical compositions of therapeutically effective amounts of the peptide compounds and a pharmaceutically acceptable carrier, diluent, or excipient for treating a disease or condition associated with complement-mediated tissue damage.
FILED Friday, August 19, 2022
APPL NO 17/821032
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/03 (20130101)
A61K 38/10 (20130101)
A61K 38/162 (20130101)
A61K 45/06 (20130101)

Peptides
C07K 7/08 (20130101) Original (OR) Class
C07K 14/005 (20130101)
C07K 14/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151064 VINETZ et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) YALE UNIVERSITY (New Haven, Connecticut)
ASSIGNEE(S)
INVENTOR(S) Joseph VINETZ (New Haven, Connecticut);  Michael MATTHIAS (New Haven, Connecticut)
ABSTRACT The invention provides compositions and methods for using Leptospiral virulence modifying (VM) proteins or fragments or fusions thereof, as vaccines and as therapeutic agents for the treatment of cancer.
FILED Thursday, February 04, 2021
APPL NO 17/760134
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/00 (20130101)

Peptides
C07K 14/20 (20130101) Original (OR) Class
C07K 2319/21 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151071 Sathyanesan et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia);  UNIVERSITY OF SOUTH DAKOTA (Vermillion, South Dakota)
ASSIGNEE(S)
INVENTOR(S) Samuel Newton Sathyanesan (Vermillion, South Dakota);  Monica Sathyanesan (Vermillion, South Dakota);  Jason Petersen (Washington, District of Columbia)
ABSTRACT Disclosed are polypeptides comprising an engineered recombinant EPO. For example, disclosed are polypeptides comprising the sequence of SEQ ID NO: 1. Disclosed are variant Epo polypeptides comprising three amino acid substitutions at positions 20, 45 and 97 of wild type human Epo. Disclosed are polynucleotides comprising a nucleic acid capable of encoding one or more of the disclosed polypeptides. Disclosed are vectors comprising any of the polynucleotides disclosed herein. Disclosed are compositions comprising the disclosed polypeptides, polynucleotides or vectors. Disclosed are cells comprising one or more of the disclosed polypeptides, one or more of the disclosed polynucleotides, and/or one or more of the disclosed vectors. Disclosed are methods of using a therapeutically effective amount of one or more of the disclosed polypeptides, nucleic acids or vectors to a subject in need thereof.
FILED Friday, April 09, 2021
APPL NO 17/917264
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/28 (20180101)

Peptides
C07K 14/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151073 Topp et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Elizabeth M. Topp (West Lafayette, Indiana);  Karthik B. Chandrababu (West Lafayette, Indiana);  Harshil K. Renawala (Thana, India)
ABSTRACT The present invention generally relates to peptides with no or substantially reduced fibrillation and their therapeutic uses, in particular to phosphorylated calcitonin peptides that have no measureable or substantially reduced fibrillation in an aqueous environment. Also described herein are pharmaceutical compositions of such compounds and methods for treating a patient suffering from pain, osteoporosis, Paget's disease, and/or hypercalcemia by administering therapeutically effective amounts of such compound alone, or together with other therapeutics, or in a pharmaceutical composition to a patient in need of relief.
FILED Friday, March 26, 2021
APPL NO 17/914207
CURRENT CPC
Peptides
C07K 14/585 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151075 Cao
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Xu Cao (Baltimore, Maryland)
ABSTRACT A method for treating low back pain (LBP) and/or osteoarthritic pain in a subject in need of treatment thereof, the method comprising administering to the subject a composition comprising a recombinant parathyroid hormone (PTH) and a pharmaceutically acceptable carrier is disclosed.
FILED Wednesday, December 02, 2020
APPL NO 17/781185
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 19/02 (20180101)

Peptides
C07K 14/635 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151094 Turtle et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Fred Hutchinson Cancer Center (Seattle, Washington)
ASSIGNEE(S) Fred Hutchinson Cancer Center (Seattle, Washington)
INVENTOR(S) Cameron J. Turtle (Seattle, Washington);  Roland B. Walter (Seattle, Washington);  George S. Laszlo (Seattle, Washington);  Salvatore Fiorenza (Seattle, Washington)
ABSTRACT Chimeric antigen receptors (CARs) with binding domains derived from a novel suite of CD33-binding antibodies are described. The CARs include optimized short and intermediate spacer regions. The current disclosure also provides methods of cell expansion/activation processes utilizing IL-2, IL-7, IL-15, and/or IL-21 that improve cellular proliferation and cell lysis of the CARs as described.
FILED Wednesday, March 31, 2021
APPL NO 17/995085
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/001111 (20180801)
A61K 2039/5156 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/02 (20180101)

Peptides
C07K 14/7051 (20130101)
C07K 16/2803 (20130101) Original (OR) Class
C07K 2319/03 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 2501/2302 (20130101)
C12N 2501/2307 (20130101)
C12N 2501/2315 (20130101)
C12N 2501/2321 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151316 Huh et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Dongeun Huh (Villanova, Pennsylvania);  Mark Mondrinos (Philadelphia, Pennsylvania)
ABSTRACT The presently disclosed subject matter provides a biomimetic organ model, and methods of its production and use. In one exemplary embodiment, the biomimetic organ model can be a multi-layer model including a at least two microchannels and at least one chamber slab with at least one membrane coated with cells disposed between at least one microchannel and the at least one chamber slab. In another exemplary embodiment, the biomimetic organ disease model can be a five-layer model including a first and second microchannel with a membrane-gel layer-membrane coated or encompassing cells disposed between the microchannels. In certain embodiments, at least one device can be coupled to the biomimetic organ model that delivers an agent to at least one microchannel.
FILED Tuesday, July 26, 2022
APPL NO 17/814948
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/18 (20130101)
A61L 27/22 (20130101)
A61L 27/50 (20130101)
A61L 27/52 (20130101)
A61L 27/3633 (20130101)
A61L 27/3804 (20130101)

Compositions of Macromolecular Compounds
C08L 83/04 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 3/00 (20130101)
C12M 21/08 (20130101) Original (OR) Class
C12M 23/16 (20130101)
C12M 23/20 (20130101)
C12M 25/02 (20130101)
C12M 25/14 (20130101)
C12M 29/10 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0018 (20130101)
C12N 5/0062 (20130101)
C12N 5/0068 (20130101)
C12N 2533/30 (20130101)
C12N 2533/54 (20130101)
C12N 2535/00 (20130101)
C12N 2537/10 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5005 (20130101)
G01N 33/5044 (20130101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 23/30 (20130101)
G09B 23/306 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151327 Gamm et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S)
INVENTOR(S) David Gamm (Waunakee, Wisconsin);  Steven Mayerl (Colorado Spring, Colorado)
ABSTRACT This disclosure relates to genetically engineered retinal organoids that can be used to test therapeutic treatments.
FILED Wednesday, August 17, 2022
APPL NO 17/820488
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0621 (20130101) Original (OR) Class
C12N 2503/02 (20130101)
C12N 2503/04 (20130101)
C12N 2513/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151342 CHOUDHARY et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE BROAD INSTITUTE, INC (CAMBRIDGE, Massachusetts);  THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (BOSTON, Massachusetts);  THE GENERAL HOSPITAL CORPORATION (BOSTON, Massachusetts);  DANA-FARBER CANCER INSTITUTE, INC. (BOSTON, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Amit CHOUDHARY (Boston, Massachusetts);  Donghyun LIM (Cambridge, Massachusetts);  Sreekanth VEDAGOPURAM (Boston, Massachusetts);  Benjamin EBERT (Boston, Massachusetts);  Max JAN (Boston, Massachusetts)
ABSTRACT The disclosure includes compositions comprising synthetic zinc finger degrons, and their use with non-naturally occurring or engineered programmable nucleases. Compositions specifically targeting the engineered programmable nucleases for control of gene editing outcomes, and compositions, systems and method of use are further detailed.
FILED Friday, February 26, 2021
APPL NO 17/802932
CURRENT CPC
Peptides
C07K 14/00 (20130101)
C07K 2319/95 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 9/78 (20130101)
C12N 15/11 (20130101)
C12N 15/635 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151363 JU et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York)
ASSIGNEE(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York)
INVENTOR(S) Jingfang JU (East Setauket, New York);  Andrew FESLER (Sound Beach, New York)
ABSTRACT The present disclosure provides modified short-interfering ribosomal nucleic acid compositions that have one or more uracil bases replaced a 5-fluorouracil molecule. More specifically, the present disclosure reveals that the replacement of uracil nucleotides within an siRNA nucleotide sequence with a 5-fluorouracil increases the ability of the short interfering RNA to inhibit cancer progression and tumorigenesis when compared to known cancer therapeutics. As such, the present disclosure provides various short-interfering nucleic acid compositions having 5-fluorouracil molecules incorporated in their nucleic acid sequences and methods for using the same. The present disclosure further provides pharmaceutical compositions comprising the modified nucleic acid compositions, and methods for treating cancers using the same.
FILED Thursday, March 18, 2021
APPL NO 17/912688
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/335 (20130101)
C12N 2320/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151364 Dudley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Samuel C. Dudley (Minneapolis, Minnesota);  Gyeoung-Jin Kang (Minneapolis, Minnesota)
ABSTRACT A method of increasing sodium current in a cardiac cell generally includes introducing into the cardiac cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of SCN5A mRNA transcription, thereby increasing sodium current in the cardiac cell. A method of increasing translation of SCN5A mRNA in a cell generally includes introducing into the cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of SCN5A mRNA transcription. A method of decreasing arrhythmia in a cardiac cell generally includes introducing into the cardiac cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of SCN5A mRNA transcription. A method of treating arrhythmia in a patient having, or at risk of having, arrhythmia generally includes administering to the patient an miR-488 inhibitor in an amount effective to decrease the likelihood or extent of arrhythmia in the patient. In some embodiments of all methods, the miR-488 inhibitor can be an miR-488 antagomir or an miR-488 sponge.
FILED Monday, April 19, 2021
APPL NO 17/919307
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 9/06 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/113 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151367 CHATURVEDI et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
APPLICANT(S) The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Glads (San Franciso, California);  VxBiosciences, Inc. (San Francisco, California)
ASSIGNEE(S)
INVENTOR(S) Sonali CHATURVEDI (San Francisco, California);  Robert RODICK (Berkeley, California);  Leor S. WEINBERGER (San Francisco, California)
ABSTRACT Described herein are compositions defective SARS-CoV-2 constructs and particles that can interfere with or block infection of uninfected cells and methods for generating such defective SARS-CoV-2 constructs and particles. The compositions and methods described herein are useful for treatment of SARS-CoV-2 infections.
FILED Friday, April 23, 2021
APPL NO 17/920682
CURRENT CPC
Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 15/1058 (20130101)
C12N 15/1065 (20130101)
C12N 15/1131 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2770/20021 (20130101)
C12N 2770/20022 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 40/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151389 Asokan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina)
INVENTOR(S) Aravind Asokan (Durham, North Carolina);  Trevor Gonzalez (Durham, North Carolina);  Lawrence Patrick Havlik (Durham, North Carolina)
ABSTRACT The present disclosure provides adeno-associated virus (AAV) vectors, comprising coevolved capsid variant proteins, pharmaceutical compositions, methods of making, and methods for delivering such to a subject.
FILED Wednesday, May 05, 2021
APPL NO 17/922962
CURRENT CPC
Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101) Original (OR) Class
C12N 2750/14122 (20130101)
C12N 2750/14143 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151423 Kaminsky et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland);  UNIVERSITY OF MARYLAND (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Zachary Kaminsky (Ottawa, Canada);  Jennifer L. Payne (Baltimore, Maryland);  Todd Gould (Baltimore, Maryland)
ABSTRACT The present invention relates to the field of post-partum depression. More specifically, the present invention relates to the use of biomarkers to diagnose post-partum depression or predict a risk thereof. In a specific embodiment, a method for identifying a likelihood of PPD in a patient comprises the steps of (a) providing a sample from the patient; (b) measuring white blood cell type counts and DNA methylation levels of a panel of biomarkers in the sample collected from the patient, wherein the panel of biomarkers comprises HP1BP3 and TTC9B and the white blood cell type counts comprise monocytes and non-monocytes; and (c) identifying the patient as likely to develop PPD based on the relative DNA methylation levels at the biomarker loci relative to the ratio of monocytes:non-monocytes.
FILED Tuesday, August 11, 2020
APPL NO 16/990572
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/16 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/154 (20130101)
C12Q 2600/158 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151430 Peled et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
ASSIGNEE(S) MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, New York)
INVENTOR(S) Jonathan U. Peled (Roosevelt Island, New York);  Marcel R.M. Van Den Brink (New York, New York);  Antonio Gomes (New York, New York)
ABSTRACT The present disclosure relates to compositions and methods for predicting cancer survival in a subject after receiving a treatment (e.g., allogeneic hematopoietic-cell transplantation). The present disclosure further discloses compositions and methods for treating said subject.
FILED Thursday, August 18, 2022
APPL NO 17/890694
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/689 (20130101)
C12Q 1/6886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151434 Gabrilovich
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Wistar Institute of Anatomy and Biology (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Dmitry I. Gabrilovich (Villanova, Pennsylvania)
ABSTRACT Provided herein are methods of method of inhibiting the recurrence of cancer in subject associated with stress-induced β-adrenergic pathway signaling. In certain embodiments, the methods include treating a subject with an inhibitor of S100A8/A9.
FILED Wednesday, April 07, 2021
APPL NO 17/995539
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152256 YU et al.
FUNDED BY
Department of Health and Human Services (HHS)
Food and Drug Administration (FDA)
APPLICANT(S) UNIVERSITY OF MARYLAND, BALTIMORE (BALTIMORE, Maryland)
ASSIGNEE(S)
INVENTOR(S) Yihua (Bruce) YU (Ellicott City, Maryland);  Marc B. TARABAN (North Potomac, Maryland)
ABSTRACT A method of using the transverse relaxation rate (R2) of solvent NMR signal to detect filling errors of an alum-containing product in real-time in-line during manufacturing, for example during a fill-finish unit operation. This technique can be used for quality control in vaccine manufacturing to ensure the delivery of the correct concentration of alum-containing product to the product container such as a vial or pre-filled syringe.
FILED Tuesday, January 03, 2023
APPL NO 18/149233
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 24/084 (20130101) Original (OR) Class
G01N 24/085 (20130101)
G01N 33/15 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152313 Farris et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Oklahoma Medical Research Foundation (Oklahoma City, Oklahoma);  The Board of Regents of the University of Oklahoma (Norman, Oklahoma)
ASSIGNEE(S)
INVENTOR(S) A. Darise Farris (Edmond, Oklahoma);  Sherri Longobardi (Oklahoma City, Oklahoma)
ABSTRACT The present invention includes a method and kit of determining that a patient negative for anti- Ro autoantibodies has Sjögren’s syndrome (SS) without performing a lip biopsy comprising: obtaining a liquid biological sample from the patient suspected of having SS; determining that the patient is negative for anti-Ro autoantibodies; and detecting autoantibodies to 1, 2, 3, 4, 5, 6, 7, 8, or 9 proteins selected from: CCDC155, DDB1, MUM1L1, NFU1, RPS29, SOX5, TCP10, ZNF655, or RPAP3, which indicate(s) that the patient has SS. Also, a lack of certain autoantibodies such as KCNAB1, KCNAB2, or as listed in Table 1, Table 2, or Table 3, and FIGS. 11 or 16 in Ro neg cases may be used to detect SS.
FILED Thursday, February 04, 2021
APPL NO 17/797619
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/564 (20130101) Original (OR) Class
G01N 2800/52 (20130101)
G01N 2800/101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152322 Mahajan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S)
INVENTOR(S) Vinit Mahajan (Palo Alto, California);  Gabriel Velez (Palo Alto, California);  Prithvi Mruthyunjaya (Redwood City, California)
ABSTRACT Compositions, methods, and kits are provided for diagnosing and treating uveal melanoma. In particular, biomarkers have been identified that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status. These biomarkers can be used alone or in combination with one or more additional biomarkers or relevant clinical parameters in prognosis, diagnosis, or monitoring treatment of uveal melanoma.
FILED Friday, January 29, 2021
APPL NO 17/796179
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57407 (20130101) Original (OR) Class
G01N 33/57488 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152324 Hanks et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Brent A. Hanks (Durham, North Carolina);  Balamayooran Theivanthiran (Durham, North Carolina)
ABSTRACT The present disclosure describes methods and markers in the NLRP3-HSP70 axis useful for making treatment decisions regarding cancer.
FILED Monday, November 14, 2022
APPL NO 18/055406
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57488 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152325 Cukierman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Institute For Cancer Research d/b/a The Research Institute Of Fox Chase Cancer Center (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Edna Cukierman (Philadelphia, Pennsylvania);  Janusz Franco-Barraza (Philadelphia, Pennsylvania);  Neelima Shah (Philadelphia, Pennsylvania)
ABSTRACT Methods for intervening in conditions of active desmoplasia comprise detecting increased levels of active alpha5-beta-1 integrin and the localization of this active integrin intracellularly away from three dimensional matrix adhesions within the stroma of affected tissues, as well as detecting the concomitant enhanced activity of focal adhesion kinase. Once active desmoplasia is detected, treatments may ensue, which induce a desmoplastic extracellular matrix to revert to a normal/innate phenotype, or which alter the standard of care to improve an outcome that would be less beneficial without the detection of a treatment-impeding desmoplasia condition. Liquid biopsies for detecting active desmoplasia are provided.
FILED Monday, June 26, 2017
APPL NO 16/310566
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57492 (20130101) Original (OR) Class
G01N 2333/7055 (20130101)
G01N 2333/91205 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152329 Ghosh et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona)
ASSIGNEE(S)
INVENTOR(S) Indraneel Ghosh (Tucson, Arizona);  Matthew Bienick (Tucson, Arizona);  Sean Campbell (Bronx, New York);  Carl Buchholz (Roanoke, Virginia)
ABSTRACT A method to produce novel split-protein sensors are described herein. The method implements a sequence dissimilarity (SD) based design that can identify potential split-sites in proteins to generate a split-protein pair, and then employs structure guided mutagenesis of the fragmented protein interface to generate split-protein sensors. The sensors have a signal to background ratio >200 and can be readily used to monitor protein-protein interactions and their inhibition in cells.
FILED Monday, March 08, 2021
APPL NO 17/905675
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/66 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6845 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152331 Ardehali et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (OAKLAND, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (OAKLAND, California)
INVENTOR(S) Reza Ardehali (LOS ANGELES, California);  Shuin Park (LOS ANGELES, California)
ABSTRACT Methods for the detection, monitoring, and treatment of cardiac fibrosis, progression of cardiac fibrosis, or heart failure in a subject comprising: (a) contacting a sample obtained from the subject with a binding agent that binds a region of cartilage intermediate layer protein 1 (CILP) that spans the cleavage site of the CILP precursor or a nucleotide encoding same. The cardiac fibrosis may be associated with one or more of: ischemia, congenital defect, familial fibrosis, infiltrative fibrosis, idiopathic fibrosis, amyloidosis, hemosiderosis, valvular disease, and other idiopathic cardiomyopathies.
FILED Thursday, April 01, 2021
APPL NO 17/995266
CURRENT CPC
Peptides
C07K 14/78 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6887 (20130101) Original (OR) Class
G01N 2800/325 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152398 THEIS et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Thomas THEIS (Raleigh, North Carolina);  Milad ABOLHASANI (Raleigh, North Carolina);  Patrick TOMHON (Raleigh, North Carolina);  Sören LEHMKUHL (Raleigh, North Carolina);  Suyong HAN (Raleigh, North Carolina)
ABSTRACT In one aspect, the disclosure relates to a compact membrane reactor for parahydrogen induced hyperpolarization, the reactor including an inner tube constructed of a semipermeable membrane, an outer tube surrounding the inner tube, and a means for controlling the magnetic field surrounding the outer tube. In some aspects, multiple compact membrane reactors can be arranged in parallel. In other aspects, the compact membrane reactor is equipped with a mechanism for magnetic field control. Also disclosed are fluid handling systems and sample preparation systems comprising the compact membrane reactors disclosed herein. The compact membrane reactor can be operated in a batch mode, a stopped-flow mode, or a continuous flow mode and can be configured to work with existing NMR spectrometers and MRI instruments.
FILED Wednesday, April 07, 2021
APPL NO 17/916703
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
G01R 33/282 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152403 Zu
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S)
INVENTOR(S) ZhongLiang Zu (Nashville, Tennessee)
ABSTRACT Imaging methods for assessing the macromolecular content, such as myelin, are of great interest for understanding brain tissue microstructure, and have shown potentials in diagnosing and prognosing demyelinating diseases. for example. Magnetization transfer (MT) is a MRI contrast mechanism that enables detection of macromolecules. Previously, the MT effect has been analyzed by a semi-quantitative method termed magnetization transfer ratio (MTR) or by a quantitative magnetization transfer (qMT) method. However, because MTR does not have enough sensitivity and specificity to myelin, and qMT takes a very long scan time, their translation into clinical scenarios has been limited. This disclosure describes a MT data analysis metric using double saturation pulse offsets and powers (dopMTR). Simulations and experiments using the systems and methods described in this disclosure show that the dopMTR yields much better sensitivity and specificity to MT effect than the conventional MTR, and requires much less scan time than the qMT.
FILED Monday, November 07, 2022
APPL NO 17/982190
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/5605 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152407 Jeong et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, Utah)
ASSIGNEE(S)
INVENTOR(S) Eun-Kee Jeong (Salt Lake City, Utah);  Kyle Jeong (Salt Lake City, Utah);  John W. Rose (Salt Lake City, Utah)
ABSTRACT A method for applying a diffusion-weighting gradient during acquisition of diffusion-weighted imaging signals from a selected portion of a nervous system of a subject. Planar diffusion-weighted spin-echo (DWSE) imaging signals and planar diffusion-weighted stimulated-echo (DWSTE) imaging signals can be obtained to provide a plurality of sets of imaging signals. At least one set of imaging signals includes DWSTE signals that are associated with a high-b-value. A signal difference between DWSE imaging signals and DWSTE imaging signals can be corrected based on respective sets of DWSE imaging signals and DWSTE imaging signals having b-values at or near zero.
FILED Thursday, November 17, 2022
APPL NO 17/989096
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/5608 (20130101)
G01R 33/5616 (20130101)
G01R 33/56341 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154009 Feng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Xue Feng (Lexington, Kentucky);  Quan Chen (Lexington, Kentucky);  Kanchan Ghimire (Arlington, Virginia)
ASSIGNEE(S)
INVENTOR(S) Xue Feng (Lexington, Kentucky);  Quan Chen (Lexington, Kentucky);  Kanchan Ghimire (Arlington, Virginia)
ABSTRACT The present disclosure relates to a method and apparatus for automatic head and neck organ segmentation. The method includes: receiving 3D images obtained by a CT system or an MRI system; processing the 3D images to transform to patient coordinate system and have the same spatial resolution and matrix size; building a deep learning framework using CNN models for organ segmentation; doubling the size of training dataset by emulating uncollected training data with mirrored images and their corresponding labels; improving the performance by predicting on original and mirrored images and averaging the output probabilities; and post-processing the output from the deep learning framework to obtain final organ segmentation.
FILED Wednesday, November 17, 2021
APPL NO 17/529188
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/168 (20170101) Original (OR) Class
G06T 2207/10081 (20130101)
G06T 2207/10088 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/20084 (20130101)
G06T 2207/20216 (20130101)
G06T 2207/30004 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154215 Bharti et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The United States of America,as represented by the Secretary,Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America,as represented by the Secretary,Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Kapil Bharti (Potomac, Maryland);  Nathan A. Hotaling (Bethesda, Maryland);  Nicholas J. Schaub (Gaithersburg, Maryland);  Carl G. Simon (Gaithersburg, Maryland)
ABSTRACT A method is provided for non-invasively predicting characteristics of one or more cells and cell derivatives. The method includes training a machine learning model using at least one of a plurality of training cell images representing a plurality of cells and data identifying characteristics for the plurality of cells. The method further includes receiving at least one test cell image representing at least one test cell being evaluated, the at least one test cell image being acquired noninvasively and based on absorbance as an absolute measure of light, and providing the at least one test cell image to the trained machine learning model. Using machine learning based on the trained machine learning model, characteristics of the at least one test cell are predicted. The method further includes generating, by the trained machine learning model, release criteria for clinical preparations of cells based on the predicted characteristics of the at least one test cell.
FILED Wednesday, November 09, 2022
APPL NO 17/983963
CURRENT CPC
Electric Digital Data Processing
G06F 18/2148 (20230101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 2207/10056 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/20084 (20130101)
G06T 2207/30024 (20130101)

Image or Video Recognition or Understanding
G06V 10/82 (20220101)
G06V 20/69 (20220101) Original (OR) Class
G06V 20/695 (20220101)
G06V 20/698 (20220101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154561 Cheng et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
APPLICANT(S) The Curators of the University of Missouri (Columbia, Missouri)
ASSIGNEE(S)
INVENTOR(S) Jianlin Cheng (Columbia, Missouri);  Elham Soltanikazemi (Columbia, Missouri);  Raj Shekhor Roy (Columbia, Missouri);  Farhan Quadir (Columbia, Missouri)
ABSTRACT Deep learning systems and methods for predicting structural aspects of protein-related complexes are described herein. An example method for predicting inter-chain distances of protein-related complexes includes receiving data associated with a protein-related complex, where the data associated with the protein-related complex includes at least one of a tertiary structural feature and a multiple sequence alignment (MSA)-derived feature. The method also includes inputting the data associated with the protein-related complex into a deep learning model. The method further includes predicting, using the deep learning model, an inter-chain distance map for the protein-related complex.
FILED Wednesday, November 16, 2022
APPL NO 17/988461
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101)
G06N 3/045 (20230101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 15/20 (20190201)
G16B 15/30 (20190201) Original (OR) Class
G16B 40/00 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154586 Castle et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) James Castle (Lexington, Kentucky);  Quan Chen (Lexington, Kentucky);  Xue Feng (Lexington, Kentucky)
ASSIGNEE(S)
INVENTOR(S) James Castle (Lexington, Kentucky);  Quan Chen (Lexington, Kentucky);  Xue Feng (Lexington, Kentucky)
ABSTRACT The present disclosure relates to a method and apparatus for fast Monte Carlo (MC) dose calculation using a virtual source model (VSM). The method includes: receiving three-dimensional (3D) images obtained by a computed tomography (CT) system; receiving 3D planned dose images, 3D organ segmentation contour images, and radiotherapy plans generated by a treatment planning system (TPS); processing all 3D images to have the same spatial resolution and matrix size; processing 3D CT images to convert image intensity to density; processing the radiotherapy plans to generate instructions on how to simulate plan delivery; building VSM using inverse cumulative density function (CDF) tables for the simulation of radiotherapy plans, wherein the step of building VSM comprises: receiving output data files containing phase-space information for the radiation output of a specific medical linear accelerator treatment head; calculating the probability of particles' inplane and crossplane positions reverse transported from the phase-space surface back to the treatment head; calculating the Gaussian means and standard deviations of particles' positions at the treatment head and determining the criteria for particle source; calculating the probabilities for each particle source; calculating the probabilities for the medical linear accelerator treatment head to produce different particle species; binning the inplane position probability information of particles into a single histogram for each source and particle species; binning the crossplane position probability information of particles into histograms for each bin of the inplane position histogram for each source and particle species; binning the inplane direction cosine probability information of particles into histograms for each bin of the inplane position histogram for each source and particle species; binning the crossplane direction cosine probability information of particles into histograms for each bin of the crossplane position histogram for each source and particle species; binning the kinetic energy probability information of particles into radially binned histograms for each source and particle species; converting probability densities for inplane and crossplane positions, inplane and crossplane direction cosines, and kinetic energies histograms into cumulative probability densities for each source and particle species; and inverting cumulative probability densities and converting into probability binned inverse CDF tables; simulating and transporting external beams using VSM through virtual treatment machines to the 3D CT densities according to radiotherapy plans to produce 3D images of simulated patient dose; and post-processing 3D planned dose, organ segmentation contour, and simulated patient dose images to obtain a final report comparing planned versus simulated dose.
FILED Wednesday, November 17, 2021
APPL NO 17/528590
CURRENT CPC
Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 2207/10081 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 15/00 (20180101)
G16H 20/10 (20180101) Original (OR) Class
G16H 30/40 (20180101)
G16H 50/50 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154618 Enderling et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, Florida)
ASSIGNEE(S)
INVENTOR(S) Heiko Enderling (New Tampa, Florida);  Stefano Pasetto (Tampa, Florida)
ABSTRACT Systems and methods utilizing a Bayesian framework for tumor forecasting are described herein. An example method may include: inputting a plurality of patient data for a patient into a multi-model framework; predicting, using the multi-model framework, a probability of a given treatment producing a given outcome for the patient; and outputting an assessment for the given treatment.
FILED Wednesday, November 16, 2022
APPL NO 18/055956
CURRENT CPC
Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 10/60 (20180101)
G16H 50/20 (20180101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 20230148878 Buller
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) The Government of the United States, as represented by the Secretary of the Army (Fort Detrick, Maryland)
ASSIGNEE(S)
INVENTOR(S) Mark J. Buller (Douglas, Massachusetts)
ABSTRACT The invention in at least one embodiment includes a system and method for detecting and evaluating an adaptive physiological strain index (aPSI) of an individual with a processor and in a further embodiment taking into account the fitness, age and clothing of the individual based upon physiology. The invention in at least one embodiment includes a system and method to calculate the aPSI using physiological measures. In at least one embodiment, the method obtains an individual's skin temperature and heart rate in order to calculate the individual's aPSI.
FILED Monday, January 23, 2023
APPL NO 18/100361
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/01 (20130101)
A61B 5/11 (20130101)
A61B 5/441 (20130101)
A61B 5/725 (20130101)
A61B 5/02055 (20130101) Original (OR) Class
A61B 2503/20 (20130101)
A61B 2562/0219 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230148951 Thatcher et al.
FUNDED BY
Department of Defense (DOD)
Defense Health Agency (DHA)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
Assistant Secretary for Preparedness and Response (ASPR)
Biomedical Advanced Research and Development Authority (BARDA)
APPLICANT(S) SPECTRAL MD, INC. (Dallas, Texas)
ASSIGNEE(S)
INVENTOR(S) Jeffrey E. Thatcher (Irving, Texas);  Wensheng Fan (Plano, Texas);  Kevin Plant (Richardson, Texas);  Faliu Yi (Allen, Texas)
ABSTRACT The present disclosure relates to systems and methods for assessing or predicting the status of wounds such as burns. Systems can include at least one light detection element and one or more processors configured to receive a signal from the at least one light detection element representing light reflected from a tissue region, generate an image having a plurality of pixels depicting the tissue region, and determine a burn status of a subset of pixels of the image using one or more deep learning algorithms. Systems can further be configured to generate a classified image of the tissue region and/or determine a predictive score associated with healing of the wound.
FILED Tuesday, January 10, 2023
APPL NO 18/152654
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0075 (20130101)
A61B 5/445 (20130101) Original (OR) Class
A61B 5/4842 (20130101)
A61B 5/7267 (20130101)
A61B 5/7275 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 2207/20084 (20130101)
G06T 2207/30088 (20130101)
G06T 2207/30101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149256 Blackburn et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina);  North Carollna State University (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Troy Blackburn (Chapel Hill, North Carolina);  Richard Lawrence Goldberg (Chapel Hill, North Carolina);  Jackson Richards (Raleigh, North Carolina);  Eric Nathan Markley (Oakland, California);  Ola Lars Anders Harrysson (Raieigh, North Carolina);  Harshad Srinivasan (Burnaby, Canada);  Vishnu Veeramachaneni (Fremont, California)
ABSTRACT A wearable local muscle vibratory stimulator includes a frame including a concave surface for conforming to a treatment surface of a subject. The stimulator further includes an electromagnetic oscillator located in the frame for applying vibratory stimulus to a treatment region of the subject located beneath the treatment surface. The stimulator further includes a waveform generator coupled to the oscillator for generating an electrical signal that causes the electromagnetic oscillator to oscillate. The stimulator further includes an accelerometer coupled to the oscillator for measuring frequency and acceleration of oscillation of the oscillator. The stimulator further includes a controller user interface for receiving user input regarding a desired frequency and acceleration of oscillation of the oscillator. The stimulator further includes a controller coupled to the oscillator and the accelerometer for receiving measurements of frequency and acceleration of oscillation of the oscillator from the accelerometer and controlling the frequency and acceleration of oscillation of the oscillator to minimize a difference between the desired frequency and acceleration of oscillation of the oscillator and the frequency and acceleration of oscillation measured by the accelerometer. The stimulator further includes means for securing the frame to the subject so that the oscillator is wearable.
FILED Wednesday, March 31, 2021
APPL NO 17/914305
CURRENT CPC
Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 23/0236 (20130101) Original (OR) Class
A61H 2201/165 (20130101)
A61H 2201/5043 (20130101)
A61H 2201/5076 (20130101)
A61H 2201/5084 (20130101)
A61H 2201/5097 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149388 FUKHARI et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (Gaithersburg, Maryland)
ASSIGNEE(S)
INVENTOR(S) Amir FUKHARI (Potomac, Maryland);  Ryan LOUGHLIN (Babridge, Ireland);  Vladimir SAVRANSKY (Rockville, Maryland);  Andrew WALKER (Dublin, Ireland)
ABSTRACT The present disclosure relates to pharmaceutical compositions comprising an opioid antagonist, isotonicity agent, a preservative agent, a stabilizing agent and citric acid. The pharmaceutical compositions are stable under various storage conditions. Methods of using the pharmaceutical compositions are also disclosed including methods of treatment
FILED Monday, April 19, 2021
APPL NO 17/919574
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/485 (20130101) Original (OR) Class
A61K 47/02 (20130101)
A61K 47/12 (20130101)
A61K 47/183 (20130101)
A61K 47/186 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 5/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149606 BURBANK et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) NxStage Medical, Inc. (Lawrence, Massachusetts)
ASSIGNEE(S) NxStage Medical, Inc. (Lawrence, Massachusetts)
INVENTOR(S) Jeffrey H. BURBANK (Manchester, Massachusetts);  Dennis M. TREU (Castle Rock, Colorado);  Daniel Joseph RUBERY, Jr. (Nashua, New Hampshire);  Scott W. NEWELL (Ipswich, Massachusetts);  James M. BRUGGER (Newburyport, Massachusetts);  William J. SCHNELL (Libertyville, Illinois);  William K. WEIGEL (Portland, Maine);  Steven A. WHITE (Hudson, Massachusetts);  Mark T. WYETH (Andover, Massachusetts);  Jerome JAMES (Vestavia, Alabama);  David DESOUZA (Essex, Massachusetts);  Joseph E. TURK, Jr. (North Andover, Massachusetts);  Garrett CASEY (Methuen, Massachusetts)
ABSTRACT The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.
FILED Tuesday, August 02, 2022
APPL NO 17/879455
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/14 (20130101)
A61M 1/34 (20130101)
A61M 1/165 (20140204)
A61M 1/341 (20140204)
A61M 1/1605 (20140204) Original (OR) Class
A61M 1/1613 (20140204)
A61M 1/1615 (20140204)
A61M 1/1647 (20140204)
A61M 1/3403 (20140204)
A61M 1/3434 (20140204)
A61M 1/3437 (20140204)
A61M 1/3441 (20130101)
A61M 1/3444 (20140204)
A61M 1/3448 (20140204)
A61M 1/3607 (20140204)
A61M 1/3609 (20140204)
A61M 1/3635 (20140204)
A61M 2205/15 (20130101)
A61M 2205/058 (20130101)
A61M 2205/502 (20130101)
A61M 2205/702 (20130101)
A61M 2205/3331 (20130101)
A61M 2205/3334 (20130101)
A61M 2205/3341 (20130101)
A61M 2205/3351 (20130101)
A61M 2205/3355 (20130101)
A61M 2205/3365 (20130101)
A61M 2205/3368 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149760 Morgan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S)
INVENTOR(S) Sarah Morgan (Raleigh, North Carolina);  Gregory Parsons (Raleigh, North Carolina);  Morgan Leyonna Willis (Raleigh, North Carolina)
ABSTRACT Provided are MOF-fabric composites having a crystalline MOF adhered directly to fibers of the fabric and methods of making MOF-fabric composites. A solution is adsorbed onto a fabric. The solution can include a metal salt, a linker, and a solvent. The solution is adsorbed onto the fabric and the fabric suspended over a heated vapor. The vapor releases onto the fabric, causing the metal salt, the linker, and the solvent to diffuse out of the polymer fibers. The linker links metal from the metal salts to form crystals attached to the fabric, and the vapor aids crystallization.
FILED Tuesday, November 15, 2022
APPL NO 17/987113
CURRENT CPC
Chemical Means for Extinguishing Fires or for Combating or Protecting Against Harmful Chemical Agents; Chemical Materials for Use in Breathing Apparatus
A62D 3/30 (20130101) Original (OR) Class
A62D 2101/02 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/226 (20130101)
B01J 20/261 (20130101)
B01J 20/262 (20130101)
B01J 20/321 (20130101)
B01J 20/3212 (20130101)
B01J 20/3219 (20130101)
B01J 20/3265 (20130101)
B01J 20/28033 (20130101)

Treating Textile Materials Using Liquids, Gases or Vapours
D06B 5/22 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 11/20 (20130101)
D06M 13/335 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149887 Rogers
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) ODH IP CORP. (New York, New York)
ASSIGNEE(S) ODH IP CORP. (New York, New York)
INVENTOR(S) Luke Rogers (Rockville, Maryland)
ABSTRACT A reactor filter washer dryer (R-FWD) apparatus and methods of using the apparatus for producing washed and dried product of a reaction is disclosed. The R-FWD comprises a vessel defining a process chamber, a filter plate laterally disposed on the vessel base, an agitator assembly, a solids discharge port in the vessel operable to remove the solid fraction of the slurry retained by the filter plate, and a filtrate outlet in the vessel for outflowing the liquid phase of the slurry filtered through the filter plate.
FILED Monday, September 12, 2022
APPL NO 17/931220
CURRENT CPC
Separation
B01D 29/05 (20130101)
B01D 39/2027 (20130101)

Mixing, e.g Dissolving, Emulsifying, Dispersing
B01F 27/90 (20220101)
B01F 35/2215 (20220101)
B01F 2101/2204 (20220101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/0013 (20130101)
B01J 19/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150197 Collino et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Rachel Collino (Goleta, California);  Tyler Ray (Goleta, California);  Matthew Begley (Goleta, California)
ABSTRACT A method of three-dimensional (3D) printing includes applying a solution to a channel. The solution includes a plurality of anisotropic particles suspending in the solution. Acoustic waves are applied to the channel. The frequency of the acoustic waves is configured to organize the plurality of anisotropic particles into one or more columns of organized anisotropic particles. The channel is connected to a printhead and a waste outlet. The solution comprising the one or more columns of organized anisotropic particles is deposited on a substrate via the printhead outlet.
FILED Friday, December 30, 2022
APPL NO 18/091816
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/112 (20170801)
B29C 64/209 (20170801) Original (OR) Class

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2063/00 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 30/00 (20141201)
B33Y 40/00 (20141201)
B33Y 70/00 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150240 Shah et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) LaunchBay LLC (North Billerica, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Apoorva P. Shah (Burlington, Massachusetts);  Binod Giri (Tewksbury, Massachusetts);  Arjan Giaya (Shrewsbury, Massachusetts)
ABSTRACT A biaxially stretchable laminated fabric composite material includes a four-way stretchable fabric and a barrier film. The barrier film and the fabric are selectively attached at a plurality of individual bond points. When the fabric is in an unstretched state, random folds are formed in the unbonded regions of the barrier film. When the fabric is in a stretched state, the random folds are partially or fully flattened to allow the biaxially stretchable laminated fabric composite material to biaxially stretch.
FILED Thursday, November 17, 2022
APPL NO 18/056441
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 7/14 (20130101) Original (OR) Class
B32B 27/12 (20130101)
B32B 27/40 (20130101)
B32B 27/306 (20130101)
B32B 37/0076 (20130101)
B32B 37/203 (20130101)
B32B 38/1875 (20130101)
B32B 2038/0076 (20130101)
B32B 2250/04 (20130101)
B32B 2305/18 (20130101)
B32B 2329/04 (20130101)
B32B 2375/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150630 Morozov et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) TELEDYNE INSTRUMENTS, INC. (Thousand Oaks, California)
ASSIGNEE(S)
INVENTOR(S) Andrey K. Morozov (North Falmouth, Massachusetts);  Clayton P. Jones (Falmouth, Massachusetts)
ABSTRACT A sound source for acoustic communication, navigation, and networking of an underwater glider may include a cylindrical body, a rigid front section disposed anteriorly to the cylindrical body, a plurality of metal rods, a resonant pipe surrounding the rods, and a rod-mounted piezo-ceramic transducer disposed between the body and the front section. Each rod may be attached at a first end to an anterior portion of the body and at a second end to a posterior portion of the front section. The pipe may be disposed between the body and the front section. The transducer may be disposed within the pipe. A posterior end of the pipe may be separated from the anterior portion of the body by a first orifice, and an anterior end of the pipe may be separated from the posterior portion of the front section by a second orifice.
FILED Thursday, November 18, 2021
APPL NO 17/455483
CURRENT CPC
Methods or Apparatus for Generating or Transmitting Mechanical Vibrations of Infrasonic, Sonic, or Ultrasonic Frequency, for Performing Mechanical Work in General
B06B 1/0651 (20130101)
B06B 2201/74 (20130101)

Offensive or Defensive Arrangements on Vessels; Mine-laying; Mine-sweeping; Submarines; Aircraft Carriers
B63G 8/04 (20130101)
B63G 8/39 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150668 Allwein et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) General Atomics Aeronautical Systems, Inc. (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Michael Joseph Allwein (San Luis Obispo, California);  Kevin David Koller (Ramona, California);  Ryan Bylard (San Diego, California);  Roy Hultenius (Encinitas, California)
ABSTRACT Features for in-flight recovery of an unmanned aerial vehicle (UAV). A towline may be deployed by a host aircraft in-flight to recover an in-flight target UAV. The towline or portion thereof may be oriented nearly vertical. The towline may have a fitting thereon. A capture mechanism on the target UAV may have one or more deployable flaps that engage with the near vertical towline and fitting. The flaps may stow to secure the target aircraft to the towline and fitting. The host aircraft may then retract the towline to pull in the target UAV to the host aircraft using a hoist system having a winch. A latching system located in a pylon of the host aircraft, which may be under a wing, may have a towline connector that engages with and secures the target UAV. The host aircraft may have multiple hoist systems for deployment and/or recovery of multiple target UAV's.
FILED Wednesday, November 17, 2021
APPL NO 17/455383
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101)
B64C 2201/021 (20130101)
B64C 2201/206 (20130101)

Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 3/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150691 Allwein et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) General Atomics Aeronautical Systems, Inc. (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Michael Joseph Allwein (San Luis Obispo, California);  James William Groves (La Mesa, California);  Kevin David Koller (Ramona, California);  Ryan Bylard (San Diego, California);  Roy Hultenius (Encinitas, California)
ABSTRACT Features for in-flight recovery of an unmanned aerial vehicle (UAV). A towline may be deployed by a host aircraft in-flight to recover an in-flight target UAV. The towline or portion thereof may be oriented nearly vertical. The towline may have a fitting thereon. A capture mechanism on the target UAV may have one or more deployable flaps that engage with the near vertical towline and fitting. The flaps may stow to secure the target aircraft to the towline and fitting. The host aircraft may then retract the towline to pull in the target UAV to the host aircraft using a hoist system having a winch. A latching system located in a pylon of the host aircraft, which may be under a wing, may have a towline connector that engages with and secures the target UAV. The host aircraft may have multiple hoist systems for deployment and/or recovery of multiple target UAV's.
FILED Wednesday, November 17, 2021
APPL NO 17/455376
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101)
B64C 2201/182 (20130101)

Ground or Aircraft-carrier-deck Installations Specially Adapted for Use in Connection With Aircraft; Designing, Manufacturing, Assembling, Cleaning, Maintaining or Repairing Aircraft, Not Otherwise Provided For; Handling, Transporting, Testing or Inspecting Aircraft Components, Not Otherwise Provided for
B64F 1/029 (20200101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150943 Goodson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Boyd M. Goodson (Carbondale, Illinois);  Eduard Y. Chekmenev (Troy, Michigan);  Bryce E. Kidd (Carbondale, Illinois);  Jamil A. Mashni (Carbondale, Illinois);  Miranda Limbach (Creal Springs, Illinois);  Yuqing Hou (Carbondale, Illinois);  Fan Shi (Houston, Texas)
ABSTRACT The present disclosure is directed to a cleavable agent for enhanced magnetic resonance generally corresponding to the formula Y-L-R, wherein Y represents a catalyst-binding moiety having at least one isotopically labeled heteroatom, L represents a cleavable bond, and R represents a hyperpolarized payload having at least one isotopically labeled carbon. Also disclosed herein is a method of cleaving the cleavable agent for enhanced magnetic resonance.
FILED Wednesday, January 04, 2023
APPL NO 18/149740
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/12 (20130101)
B01J 2531/827 (20130101)

Heterocyclic Compounds
C07D 213/46 (20130101)
C07D 213/63 (20130101)
C07D 233/60 (20130101) Original (OR) Class
C07D 241/12 (20130101)
C07D 401/06 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/6506 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
G01R 33/282 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150986 Lindsley et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Craig W. Lindsley (Brentwood, Tennessee);  P. Jeffrey Conn (Nashville, Tennessee);  Aaron M. Bender (Spring Hill, Tennessee);  Katrina A. Bollinger (Murfreesboro, Tennessee);  Trever R. Carter (Nashville, Tennessee);  Jerri M. Rook (Nashville, Tennessee);  Jonathan W. Dickerson (Nashville, Tennessee);  Julie L. Engers (Brentwood, Tennessee);  Kayla J. Temple (Spring Hill, Tennessee);  Changho Han (Nashville, Tennessee);  Matthew Spock (Nashville, Tennessee);  Logan A. Baker (Thompson's Station, Tennessee);  Thomas M. Bridges (Nashville, Tennessee)
ABSTRACT Disclosed herein are 2,3,5-trifluorophenyl-pyridazine substituted hexahydro-1H-cyclopenta[c]pyrrole compounds, useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4) Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.
FILED Thursday, December 10, 2020
APPL NO 17/784365
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/05 (20130101)
C07B 2200/09 (20130101)

Heterocyclic Compounds
C07D 401/14 (20130101)
C07D 403/12 (20130101)
C07D 405/14 (20130101) Original (OR) Class
C07D 409/14 (20130101)
C07D 498/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151287 Trelles et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Soldier Center (CCDC SC)
APPLICANT(S) University of Massachusetts (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Juan Pablo Trelles (Sudbury, Massachusetts);  Hsi-Wu Wong (Burlington, Massachusetts);  John Hunter Mack (Arlington, Massachusetts)
ABSTRACT A first voltage source produces a first voltage such as an AC voltage. Further, a first electrode of a hydrogen generation system conveys the first voltage. The first voltage conveyed over the first electrode generates low-temperature plasma extending between the first electrode and the mass of material. Presence of the low-temperature plasma releases gas from the mass of material.
FILED Thursday, November 10, 2022
APPL NO 17/984673
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/088 (20130101)
B01J 2219/0809 (20130101)
B01J 2219/0869 (20130101)
B01J 2219/0879 (20130101)
B01J 2219/0896 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 3/02 (20130101)

Production of Producer Gas, Water-gas, Synthesis Gas From Solid Carbonaceous Material, or Mixtures Containing These Gases; Carburetting Air or Other Gases
C10J 3/72 (20130101) Original (OR) Class
C10J 2300/0946 (20130101)
C10J 2300/1238 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151342 CHOUDHARY et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of the Navy (DON)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE BROAD INSTITUTE, INC (CAMBRIDGE, Massachusetts);  THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (BOSTON, Massachusetts);  THE GENERAL HOSPITAL CORPORATION (BOSTON, Massachusetts);  DANA-FARBER CANCER INSTITUTE, INC. (BOSTON, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Amit CHOUDHARY (Boston, Massachusetts);  Donghyun LIM (Cambridge, Massachusetts);  Sreekanth VEDAGOPURAM (Boston, Massachusetts);  Benjamin EBERT (Boston, Massachusetts);  Max JAN (Boston, Massachusetts)
ABSTRACT The disclosure includes compositions comprising synthetic zinc finger degrons, and their use with non-naturally occurring or engineered programmable nucleases. Compositions specifically targeting the engineered programmable nucleases for control of gene editing outcomes, and compositions, systems and method of use are further detailed.
FILED Friday, February 26, 2021
APPL NO 17/802932
CURRENT CPC
Peptides
C07K 14/00 (20130101)
C07K 2319/95 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101) Original (OR) Class
C12N 9/78 (20130101)
C12N 15/11 (20130101)
C12N 15/635 (20130101)
C12N 15/907 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151352 FUNKNER et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) CureVac Manufacturing GmbH (Tübingen, Germany)
ASSIGNEE(S) CureVac Manufacturing GmbH (Tübingen, Germany)
INVENTOR(S) Andreas FUNKNER (Tübingen, Germany);  Stefanie DORNER (Tübingen, Germany);  Stefanie SEWING (Tübingen, Germany);  Johannes KAMM (Tübingen, Germany);  Norbert BROGHAMMER (Tübingen, Germany);  Thomas KETTERER (Gomaringen, Germany);  Thorsten MUTZKE (Reutlingen, Germany)
ABSTRACT The present invention relates to method for producing and purifying RNA comprising the steps of providing DNA encoding the RNA; transcription of the DNA into RNA; and conditioning and/or purifying of the solution comprising transcribed RNA by one or more steps of tangential flow filtration (TFF).
FILED Tuesday, August 16, 2022
APPL NO 17/820242
CURRENT CPC
Separation
B01D 61/145 (20130101)
B01D 71/12 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1017 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 19/34 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 30/02 (20130101)
G01N 2030/027 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151367 CHATURVEDI et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
APPLICANT(S) The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Glads (San Franciso, California);  VxBiosciences, Inc. (San Francisco, California)
ASSIGNEE(S)
INVENTOR(S) Sonali CHATURVEDI (San Francisco, California);  Robert RODICK (Berkeley, California);  Leor S. WEINBERGER (San Francisco, California)
ABSTRACT Described herein are compositions defective SARS-CoV-2 constructs and particles that can interfere with or block infection of uninfected cells and methods for generating such defective SARS-CoV-2 constructs and particles. The compositions and methods described herein are useful for treatment of SARS-CoV-2 infections.
FILED Friday, April 23, 2021
APPL NO 17/920682
CURRENT CPC
Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101)
C12N 15/1058 (20130101)
C12N 15/1065 (20130101)
C12N 15/1131 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2770/20021 (20130101)
C12N 2770/20022 (20130101)

Combinatorial Chemistry; Libraries, e.g Chemical Libraries
C40B 40/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151434 Gabrilovich
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Wistar Institute of Anatomy and Biology (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Dmitry I. Gabrilovich (Villanova, Pennsylvania)
ABSTRACT Provided herein are methods of method of inhibiting the recurrence of cancer in subject associated with stress-induced β-adrenergic pathway signaling. In certain embodiments, the methods include treating a subject with an inhibitor of S100A8/A9.
FILED Wednesday, April 07, 2021
APPL NO 17/995539
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151437 Cohen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Adam Ezra Cohen (Cambridge, Massachusetts);  Dingchang Lin (Cambridge, Massachusetts);  Xiuyuan E. Li (Cambridge, Massachusetts);  Doyeon Kim (Cambridge, Massachusetts)
ABSTRACT The present disclosure provides methods for profiling cellular events in a cell over time using protein assemblies. Methods for profiling the effect of a stimulus, such as a candidate therapeutic agent, are also provided by the present disclosure. Proteins, polynucleotides (e.g., vectors), and pairs of polynucleotides for use in the methods described herein, as well as systems and kits comprising such proteins, polynucleotides, and pairs of polynucleotides, are also provided herein.
FILED Wednesday, October 12, 2022
APPL NO 18/046076
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/1205 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6897 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151492 Timler et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Science Applications International Corporation (Reston, Virginia)
ASSIGNEE(S)
INVENTOR(S) John P. Timler (River Ridge, Louisiana);  David M. Morris (Bloomington, Indiana)
ABSTRACT Catalyst ink may be directly printed to a substrate using a stamp. Printed catalyst ink may converted to a pattern of one or more metal traces. Materials for a stamp and/or a substrate, and/or components of a catalyst ink, may be selected based on attraction of one or more of components of the catalyst ink to one or more print surfaces of the substrate and/or to one or more write surfaces of the stamp.
FILED Tuesday, November 16, 2021
APPL NO 17/527607
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 23/44 (20130101)
B01J 35/006 (20130101)
B01J 35/0013 (20130101)
B01J 37/345 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 11/03 (20130101)
C09D 11/14 (20130101)
C09D 11/107 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 18/30 (20130101)
C23C 18/38 (20130101)
C23C 18/1608 (20130101)
C23C 18/2053 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0002 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151779 Nemanick et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S)
INVENTOR(S) Eric Joseph Nemanick (Santa Monica, California);  Andrea Hsu (El Segundo, California);  John Schilling (Lancaster, California);  John Desain (Redondo Beach, California);  Brian Brady (Seal Beach, California);  Andrew Cortopassi (Running Springs, California)
ABSTRACT Solid rocket motors are provided herein. In certain embodiments, a solid rocket motor includes a housing containing thin layers of fuel and thin layers of an inert oxidizer, separated by a thin nonconductive layer. The housing has a nozzle at the end for gas release and channeling. Prior to use, the inert oxidizer is activated by electrochemical oxidation which can generate an active oxidizer and additional fuel. Ignition of the oxidizer and fuel can be triggered whereby the contents of the housing can ignite, generating hot gasses to be channeled out through the nozzle to generate thrust. Replacing current state solid rocket motors with embodiments described herein can improve cost, safety and increase capability. The disclosed embodiments can be safe to transport, store, and handle. Additionally, there can be no moving parts unlike hybrid or liquid rocket motors.
FILED Friday, November 12, 2021
APPL NO 17/454691
CURRENT CPC
Jet-propulsion Plants
F02K 9/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152167 Hubble et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) David O. Hubble (King George, Virginia);  Peter L. Wick, Jr. (Fredericksburg, Virginia)
ASSIGNEE(S) United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) David O. Hubble (King George, Virginia);  Peter L. Wick, Jr. (Fredericksburg, Virginia)
ABSTRACT A spinning flat plate calorimeter device is provided for receiving and measuring laser energy. The device includes a circular disk, a shaft, a structure and a motor. The circular disk has temperature-detection instrumentation for measuring temperature from the laser energy. The shaft is supported by distal and proximal bearings. The structure supports the disk, shaft and its bearings. The motor turns the shaft and the disk. Additionally, the disk further includes a flat plate, a yoke wheel and a plurality of spacers. The plate has an obverse face for receiving the laser energy and a reverse face with a spiral groove for attaching the instrumentation. The yoke wheel attaches to the shaft. The thermal isolator spacers mechanically attach the yoke wheel to the flat plate.
FILED Friday, October 28, 2022
APPL NO 17/975888
CURRENT CPC
Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 7/18 (20130101)
G01K 17/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152309 Glavin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Government of the United States, as represented by the Secretary of the Air Force (Wright-Patterson AFB, Ohio)
ASSIGNEE(S)
INVENTOR(S) Nicholas R. Glavin (Springboro, Ohio);  Christopher Muratore (Kettering, Ohio);  Melani K. Muratore (Kettering, Ohio)
ABSTRACT The present invention relates to sensor arrays that are more accurate, more sensitive, and more specific with respect to the material that is detected and capable of detecting one or more materials over a wide range. Such sensor arrays can comprises sensors comprising pattern illumination-based annealed coated substrate and one or more functional molecules and process of using same. The method of designing and process of making the sensors for such sensor array yields components that can have one or more electronic and/or optical functionalities that are integrated on the same substrate or film and to which one or more functional molecules can be attached to yield a sensor. Such processes when coupled with the design methods provided herein, allow for the rapid, efficient device prototyping, design change and evolution in the lab and on the production side.
FILED Wednesday, November 10, 2021
APPL NO 17/523705
CURRENT CPC
Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 14/0623 (20130101)
C23C 14/5813 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/125 (20130101)
G01N 33/5438 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152430 Pascoguin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
Naval Information Warfare Center Pacific (NIWCPACIFIC)
APPLICANT(S) Naval Information Warfare Center Pacific (San Diego, California)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (San Diego, California)
INVENTOR(S) Bienvenido Melvin L. Pascoguin (San Diego, California);  Brittany Lynn (San Diego, California)
ABSTRACT A method for jamming a target includes aiming a pulsed laser at the target using a tracking system. The pulsed laser emits a pulsed laser beam at the target, thereby generating plasma that causes sound waves equal to or less than 5 ft from the target. The pulsed laser beam is swept with a frequency range to find a target frequency, thereby jamming the target.
FILED Monday, November 15, 2021
APPL NO 17/526406
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/495 (20130101) Original (OR) Class
G01S 17/66 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152478 DRUKIER et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) IMAGE INSIGHT INC. (East Hartford, Connecticut)
ASSIGNEE(S)
INVENTOR(S) Gordon A. DRUKIER (New Haven, Connecticut);  Eric P. RUBENSTEIN (Ellington, Connecticut);  Yonatan B. RUBENSTEIN (Ellington, Connecticut);  Joshua C. KESSLER (San Diego, California);  Peter R. SOLOMON (West Hartford, Connecticut);  Marek A. WOJTOWICZ (East Hartford, Connecticut)
ABSTRACT Systems and methods for calibrating multiple electronic devices are described herein. Such methods may include obtaining, by a processor, data from a plurality of reference electronic devices, analyzing, by a processor, the data and calibrating, by the processor, the electronic device based on the analyzed data obtained from the plurality of reference electronic devices.
FILED Wednesday, July 20, 2022
APPL NO 17/869159
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 1/02 (20130101)
G01T 7/005 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152486 Ulmer et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Warfare Center (NAWC)
APPLICANT(S) INTELLISENSE SYSTEMS, INC. (Torrance, California)
ASSIGNEE(S)
INVENTOR(S) Christopher Ulmer (San Pedro, California);  David Miller (San Pedro, California);  Anthony Michael (Los Angeles, California);  Thomas Vu (Rancho Palos Verdes, California);  Jeffrey Norell (Los Angeles, California);  David Gustavson (Los Angeles, California);  Gregory Peng (Long Beach, California);  Drew Yenzer (Culver City, California);  Haider Rasool (Redondo Beach, California)
ABSTRACT An assembly and method for using weather sensors with enhanced modular capability is disclosed. The weather sensor assembly generally comprises a cap module, middle module, and a base module, where the cap module, middle module(s) and the base module are stacked adjacently to provide environmental sealing, weather sensing, and electrical connectivity to the weather sensor assembly. One or more ring mechanisms may be included that interlock the cap module, middle module(s), base module to form the weather sensor assembly into an integrated unit. Moreover, the ring mechanisms enable further modules to be added to the weather sensor assembly for additional capabilities. By doing so, each of the modules in the weather sensor assembly may be independent units that can be removed, reordered, swapped, and added for desired sensing modalities and environments.
FILED Friday, January 20, 2023
APPL NO 18/099716
CURRENT CPC
Meteorology
G01W 1/04 (20130101) Original (OR) Class
G01W 1/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152550 Hubble et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) David O. Hubble (King George, Virginia);  Evan Manley Bates (Fredericksburg, Virginia);  Peter L. Wick, JR. (Fredericksburg, Virginia)
ASSIGNEE(S) United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) David O. Hubble (King George, Virginia);  Evan Manley Bates (Fredericksburg, Virginia);  Peter L. Wick, JR. (Fredericksburg, Virginia)
ABSTRACT An actuator mechanism is provided for disposing a plurality of filters into and out of a camera line-of-sight. The mechanism includes a base, a pair of frames, an axial shaft, a plurality of filter housings and a plurality of pivotable drivers. The base includes an auxiliary platform. The frames flank the base, and the shaft is disposed between the frames. Each filter housing holds a corresponding optical filter and is disposable in a deployment position in the line-of-sight and a withdrawn position out of the line-of-sight. The drivers are disposed on the platform. Each driver corresponds to an associated housing and is rotatable along the shaft to swing at least one housing between deployment and withdrawn positions upon command.
FILED Friday, November 12, 2021
APPL NO 17/524886
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 7/006 (20130101) Original (OR) Class

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 11/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152754 ALLEN
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) The Aerospace Corporation (El Segundo, California)
INVENTOR(S) David W. ALLEN (Fairfax, Virginia)
ABSTRACT A system and method for periodically varying a center frequency for assured time transfer in order to securely transfer a signal from a source to a receiver, without adding additional encryption to signal.
FILED Thursday, November 18, 2021
APPL NO 17/529657
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 19/04 (20130101)
G01S 19/215 (20130101) Original (OR) Class

Wireless Communication Networks
H04W 12/03 (20210101)
H04W 12/108 (20210101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153124 ZHAO et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Intelligent Fusion Technology, Inc. (Germantown, Maryland)
ASSIGNEE(S)
INVENTOR(S) Qi ZHAO (Germantown, Maryland);  Yi LI (Germantown, Maryland);  Mingjie FENG (Germantown, Maryland);  Li LI (Germantown, Maryland);  Genshe CHEN (Germantown, Maryland)
ABSTRACT An edge network computing system includes: a plurality of terminal devices; a plurality of edge servers connected to the terminal device through an access network; and a plurality of cloud servers connected to the plurality of edge servers through a core network. Each edge server is configured to: receive a plurality of computing tasks originated from one of the plurality of terminal devices; use a deep Q-learning neural network (DQN) with experience replay to select one of the plurality of could servers to offload a portion of the plurality of computing tasks; and send the portion of the plurality of computing tasks to the selected cloud server and forward results of the portion of the plurality of computing tasks received from the selected cloud server to the originating terminal device.
FILED Thursday, September 30, 2021
APPL NO 17/490861
CURRENT CPC
Electric Digital Data Processing
G06F 9/4806 (20130101)
G06F 9/44594 (20130101) Original (OR) Class
G06F 2209/509 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153573 Principe et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
Space Vehicles Directorate (AFRL/RV)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) University of Florida Research Foundation, Incorporated (Gainesville, Florida)
ASSIGNEE(S)
INVENTOR(S) Jose C. Principe (Gainesville, Florida);  Bo Hu (Gainesville, Florida)
ABSTRACT Various embodiments are directed to configuring or training deep neural network (DNN) machine learning models comprising one or more hidden layers and an output layer. Various embodiments provide technical advantages in training DNN machine learning models, including improved computational efficiency and guaranteed optimality. In one embodiment, an example method includes identifying a nonlinear-model-based representation for each hidden layer, which may be a Bank of Wiener Models, a nonlinear units of the hidden layer, and/or the like. The method further includes individually and sequentially configuring the hidden layers, each configured by determining a correlation measure (e.g., a correlation ratio) between the layer output and a target signal. Parameters of the particular hidden layer are modified by maximizing the correlation measure to yield maximal correlation over the space of functions. The method further includes performing automated tasks using the DNN machine learning model after configuring its parameters on a training set.
FILED Thursday, November 03, 2022
APPL NO 18/052400
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/04 (20130101) Original (OR) Class
G06N 3/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153595 Fok et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Femtosense, Inc. (San Bruno, California)
ASSIGNEE(S) Femtosense, Inc. (San Bruno, California)
INVENTOR(S) Sam Brian Fok (San Leandro, California);  Alexander Smith Neckar (Redwood City, California)
ABSTRACT Systems, apparatus, and methods for thread-based scheduling within a multicore processor. Neural networking uses a network of connected nodes (aka neurons) to loosely model the neuro-biological functionality found in the human brain. Various embodiments of the present disclosure use thread dependency graphs analysis to decouple scheduling across many distributed cores. Rather than using thread dependency graphs to generate a sequential ordering for a centralized scheduler, the individual thread dependencies define a count value for each thread at compile-time. Threads and their thread dependency count are distributed to each core at run-time. Thereafter, each core can dynamically determine which threads to execute based on fulfilled thread dependencies without requiring a centralized scheduler.
FILED Monday, January 02, 2023
APPL NO 18/149142
CURRENT CPC
Electric Digital Data Processing
G06F 9/48 (20130101)
G06F 9/3802 (20130101)
G06F 9/3818 (20130101)
G06F 9/3836 (20130101)
G06F 9/3838 (20130101)
G06F 9/3851 (20130101)
G06F 9/3885 (20130101)
G06F 11/3024 (20130101)
G06F 11/3433 (20130101)
G06F 15/7807 (20130101)
G06F 16/901 (20190101)
G06F 17/16 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/10 (20130101)
G06N 3/045 (20230101)
G06N 3/048 (20230101)
G06N 3/063 (20130101) Original (OR) Class

Coding; Decoding; Code Conversion in General
H03M 7/702 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153596 Fok et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Femtosense, Inc. (San Bruno, California)
ASSIGNEE(S) Femtosense, Inc. (San Bruno, California)
INVENTOR(S) Sam Brian Fok (San Leandro, California);  Alexander Smith Neckar (Redwood City, California)
ABSTRACT Systems, apparatus, and methods for thread-based scheduling within a multicore processor. Neural networking uses a network of connected nodes (aka neurons) to loosely model the neuro-biological functionality found in the human brain. Various embodiments of the present disclosure use thread dependency graphs analysis to decouple scheduling across many distributed cores. Rather than using thread dependency graphs to generate a sequential ordering for a centralized scheduler, the individual thread dependencies define a count value for each thread at compile-time. Threads and their thread dependency count are distributed to each core at run-time. Thereafter, each core can dynamically determine which threads to execute based on fulfilled thread dependencies without requiring a centralized scheduler.
FILED Monday, January 02, 2023
APPL NO 18/149145
CURRENT CPC
Electric Digital Data Processing
G06F 9/48 (20130101)
G06F 9/3802 (20130101)
G06F 9/3818 (20130101)
G06F 9/3836 (20130101)
G06F 9/3838 (20130101)
G06F 9/3851 (20130101)
G06F 9/3885 (20130101)
G06F 11/3024 (20130101)
G06F 11/3433 (20130101)
G06F 15/7807 (20130101)
G06F 16/901 (20190101)
G06F 17/16 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/10 (20130101)
G06N 3/045 (20230101)
G06N 3/048 (20230101)
G06N 3/063 (20130101) Original (OR) Class

Coding; Decoding; Code Conversion in General
H03M 7/702 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153605 TANG
FUNDED BY
Department of Defense (DOD)
Defense Health Agency (DHA)
APPLICANT(S) THE MITRE CORPORATION (MCLEAN, Virginia)
ASSIGNEE(S)
INVENTOR(S) HUANG TANG (MCLEAN, Virginia)
ABSTRACT Disclosed herein are system, method, and computer program product embodiments for generating a disease severity index based on a machine learning system executing a one-dimensional convolutional neural network (CNN) using a large kernel. An embodiment operates by collecting training data sets, extracting a training data feature set from the training data sets, weighting features in the training data feature set to generate a weighted training data feature set, selecting a large kernel comprising the weighted training data feature set, executing a one-dimensional convolution of the weighted training data feature set based on the large kernel to generate an aggregation of weighted occurrences and generating an index based on the aggregation of weighted occurrences.
FILED Monday, September 19, 2022
APPL NO 17/947637
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101) Original (OR) Class

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 50/70 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153669 McKay et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S)
INVENTOR(S) David C. McKay (Ossining, New York);  Jay M. Gambetta (Yorktown Heights, New York)
ABSTRACT A quantum computing device including a first plurality of qubits having a first resonance frequency and a second qubit having a second resonance frequency, the second resonance frequency being different from the first resonance frequency; and a first tunable frequency bus configured to couple the first plurality of qubits to the second qubit.
FILED Friday, January 06, 2023
APPL NO 18/151039
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153676 Freedman et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOE-SC)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The University of Chicago (Chicago, Illinois);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Danna E. Freedman (Evanston, Illinois);  David D. Awschalom (Chicago, Illinois);  Dan W. Laorenza (Evanston, Illinois);  Majed S. Fataftah (New Haven, Connecticut);  Sam L. Bayliss (Chicago, Illinois);  Berk Diler (Chicago, Illinois);  Peter J. Mintun (Chicago, Illinois)
ABSTRACT A molecular-spin qubit is formed from a coordination complex having a plurality of strong-field ligands bound to a metal-atom center. The ground state has non-zero spin, and the resulting ground-state magnetic sublevels are separated by microwave or millimeter-wave frequencies, even in the absence of an external field. Two of these sublevels may be used as a quantum resource for quantum information processing, quantum communication, quantum memory, sensing, and other applications. Optical pumping to an excited state may be used to spin-polarize the molecular-spin qubit, and to measure its population by detecting photoluminescence. The energy-level structure of the metal-atom center can be modified due to its interaction with the ligands, therefore allowing the molecular-spin qubit to be “chemically tuned” based on the number and type of ligands. Ensembles of these molecular-spin qubits can be controllably deposited on a surface, or otherwise integrated into devices and structures.
FILED Friday, April 09, 2021
APPL NO 17/995825
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/13 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/2208 (20130101)
C07F 11/00 (20130101)

Computer Systems Based on Specific Computational Models
G06N 10/40 (20220101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154639 Levy
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Jeremy Levy (Pittsburgh, Pennsylvania)
ABSTRACT Described is a method comprising directing an ultra-low voltage electron beam to a surface of a first insulating layer. The first insulating layer is disposed on a second insulating layer. The method includes modifying, by the application of the ultra-low voltage electron beam, the surface of the first insulating layer to selectively switch an interface between a first state having a first electronic property and a second state having a second electronic property.
FILED Thursday, February 11, 2021
APPL NO 17/917669
CURRENT CPC
Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 5/04 (20130101) Original (OR) Class

Electric Discharge Tubes or Discharge Lamps
H01J 37/28 (20130101)
H01J 37/147 (20130101)
H01J 37/3174 (20130101)
H01J 2237/004 (20130101)

Electric solid-state devices not otherwise provided for
H10N 52/01 (20230201)
H10N 60/01 (20230201)
H10N 60/30 (20230201)
H10N 70/041 (20230201)
H10N 70/257 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154717 Borchard et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Dymenso LLC (San Francisco, California)
ASSIGNEE(S)
INVENTOR(S) Philipp Borchard (San Francisco, California);  Joseph S. Hoh (Richmond, California)
ABSTRACT A high-power vacuum electron device source of 10 mm-0.1 mm wavelength radiation is composed of an electron gun joined to a RF vacuum electronic circuit. The electron gun includes a cathode, a focus electrode, and a grid. It generates an electron beam that is injected into the circuit for amplifying RF waves. The circuit is composed of metal circuit plates, e.g., copper alloy, that mate with each other and are shaped to provide a beam tunnel and RF circuit envelopes. Precision alignment pins made of nickel super alloy, are used to mutually align the metal circuit plates using elastic averaging implemented by positioning the precision alignment pins in precision alignment holes in the metal circuit plates. Preferably, the electron gun is aligned with the circuit using quasi-kinematic coupling.
FILED Thursday, November 18, 2021
APPL NO 17/530042
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 29/04 (20130101)
H01J 29/54 (20130101)
H01J 29/66 (20130101) Original (OR) Class
H01J 2223/083 (20130101)
H01J 2229/481 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154875 Piedra et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Analog Devices, Inc. (Wilmington, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Daniel Piedra (Somerville, Massachusetts);  James G. Fiorenza (Carlisle, Massachusetts);  Puneet Srivastava (Wilmington, Massachusetts);  Andrew Proudman (Medford, Massachusetts);  Kenneth Flanders (Reading, Massachusetts);  Denis Michael Murphy (Concord, Massachusetts);  Leslie P. Green (Framingham, Massachusetts);  Peter R. Stubler (Andover, Massachusetts)
ABSTRACT Gallium nitride-based monolithic microwave integrated circuits (MMICs) can comprise aluminum-based metals. Electrical contacts for gates, sources, and drains of transistors can include aluminum-containing metallic materials. Additionally, connectors, inductors, and interconnect devices can also comprise aluminum-based metals. The gallium-based MMICs can be manufactured in complementary metal oxide semiconductor (CMOS) facilities with equipment that produces silicon-based semiconductor devices.
FILED Friday, December 30, 2022
APPL NO 18/148982
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/8252 (20130101)
H01L 21/28575 (20130101)
H01L 23/66 (20130101) Original (OR) Class
H01L 23/481 (20130101)
H01L 23/53214 (20130101)
H01L 27/0605 (20130101)
H01L 27/0629 (20130101)
H01L 28/60 (20130101)
H01L 29/205 (20130101)
H01L 29/452 (20130101)
H01L 29/2003 (20130101)
H01L 29/7786 (20130101)
H01L 29/66462 (20130101)
H01L 2223/6616 (20130101)
H01L 2223/6683 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155136 Smith
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
INVENTOR(S) Kyle Christopher Smith (Champaign, Illinois)
ABSTRACT Aspects of the subject disclosure may include, for example, a porous device, comprising a porous material, and a hierarchical network of flow channels defined in the porous material, wherein at least one flow channel in the hierarchical network of flow channels has a shape that at least partially approximates a cube-root profile or a quartic-root profile. Additional embodiments are disclosed.
FILED Thursday, November 03, 2022
APPL NO 17/980023
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 80/00 (20141201)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/8626 (20130101) Original (OR) Class
H01M 4/8878 (20130101)
H01M 8/0258 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155168 Lin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Bioenno Tech LLC (Santa Ana, California)
ASSIGNEE(S)
INVENTOR(S) Zhigang Lin (Santa Ana, California);  Chunhu Tan (Santa Ana, California);  Tianyu Meng (Santa Ana, California)
ABSTRACT Electrolyte-infiltrated composite electrode includes an electrolyte component consisting of a polymer matrix with ceramic nanoparticles embedded in the matrix to form a networking structure of electrolyte. Suitable ceramic nanoparticles have the basic formula Li7La3Zr2O12 (LLZO) and its derivatives such as AlxLi7-xLa3Zr2-y-zTayNbzO12 where x ranges from 0 to 0.85, y ranges from 0 to 0.50 and z ranges from 0 to 0.75, wherein at least one of x, y and z is not equal to 0. The networking structure of the electrolyte establishes an effective lithium-ion transport pathway in the electrode and strengthens the contact between electrode layer and solid-state electrolyte resulting in higher lithium-ion electrochemical cell's cycling stability and longer battery life. Sold-state electrolytes incorporating the ceramic particles demonstrate improved performance. Large dimensional electrolyte-infiltrated composite electrode sheets can be used in all solid-state lithium electrochemical pouch cells which can be assembled into battery packs.
FILED Monday, January 16, 2023
APPL NO 18/097384
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 4/622 (20130101)
H01M 4/625 (20130101)
H01M 10/0525 (20130101)
H01M 10/0562 (20130101) Original (OR) Class
H01M 2004/021 (20130101)
H01M 2300/0071 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155179 Ma et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) U.S. Army DEVCOM, Army Research Laboratory (Adelphi, Maryland)
ASSIGNEE(S)
INVENTOR(S) Lin Ma (Silver Spring, Maryland);  Marshall A. Schroeder (Pasadena, Maryland);  Oleg A. Borodin (Laurel, Maryland);  Travis P. Pollard (Rockville, Maryland);  Michael S. Ding (Potomac, Maryland);  Kang Xu (Potomac, Maryland)
ABSTRACT An electrochemical cell includes a negative electrode including a metal, metal alloy, or an electrode active material that reversibly intercalates and de-intercalates cations; a positive electrode including (i) an electrode active material that reversibly intercalates and de-intercalates cations or anions, or (ii) an inert host that reversibly catalyzes an external reactant; a separator between the negative electrode and the positive electrode; and an electrolyte including one or more alcohol-based solvents, with one or more salts. The solvents may include methanol, ethanol, isopropanol, triglycerol, 2,2,2-trifluoroethanol, an organic small molecule or macromolecule that contain at least one hydroxyl (OH) group, or a combination thereof. The electrochemical cell may include a mixture of multiple alcohol-based solvents or a mixture of the one or more alcohol-based solvents with water, mixed at select ratios. The electrochemical cell may include one or more additives having a concentration range between 0.01% to 20% by weight.
FILED Wednesday, November 17, 2021
APPL NO 17/528719
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/42 (20130101)
H01M 4/463 (20130101)
H01M 4/466 (20130101)
H01M 10/0567 (20130101)
H01M 10/0569 (20130101) Original (OR) Class
H01M 50/417 (20210101)
H01M 50/437 (20210101)
H01M 2300/0042 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155836 Burnett et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Architecture Technology Corporation (Minneapolis, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Benjamin L. Burnett (Prior Lake, Minnesota);  Jafar Al-Gharaibeh (Eden Prairie, Minnesota)
ABSTRACT In general, the techniques of this disclosure describe a system for secure serverless authentication. An authenticator node of the system may receive indications of values of authentication factors associated with an entity. The authenticator node may hash the values of the authentication factors to generate double hashed values of the authentication factors. The authenticator node may compare the double hashed values of the authentication factors with trusted authentication information that is encoded in entity credentials associated with the entity. The authenticator node may determine, based at least in part on comparing the double hashed values of the authentication factors with the trusted authentication information, whether the entity is a trusted entity.
FILED Monday, September 12, 2022
APPL NO 17/931407
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/0643 (20130101)
H04L 9/3231 (20130101)
H04L 9/3236 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155962 Ho et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
Naval Information Warfare Center Pacific (NIWCPACIFIC)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Thang Hoang Ho (San Diego, California);  Christina Marie de Jesus (La Mesa, California)
ABSTRACT A system with flexible communication interconnections includes devices and a layer-one switch interconnecting disjoint pairings of communication interfaces. The devices each have at least one communication interface. The layer-one switch has ports, each coupled to a respective one of the communication interfaces, which include the communication interface of each of the devices. For every pairing of a first and different second one of the ports within the disjoint pairings, the layer-one switch is configurable to interconnect bidirectional communications between the respective communication interface for the first port and the respective communication interface for the second port.
FILED Thursday, November 18, 2021
APPL NO 17/530310
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 41/0866 (20130101)
H04L 49/15 (20130101) Original (OR) Class
H04L 69/323 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230156473 MELODIA et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Missile Defense Agency (MDA)
APPLICANT(S) Northeastern University (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Tommaso MELODIA (Newton, Massachusetts);  Francesco RESTUCCIA (Boston, Massachusetts);  Salvatore D'ORO (Allston, Massachusetts)
ABSTRACT A method of determining a response of a radio frequency wireless communication system to an adversarial attack is provided. Adversarial signals from an adversarial node are transmitted to confuse a target neural network of the communication system. An accuracy of classification of the incoming signals by the target neural network is determined.
FILED Monday, December 21, 2020
APPL NO 17/128437
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 41/16 (20130101)

Wireless Communication Networks
H04W 12/122 (20210101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 20230149528 Rieder et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  Triad National Security, LLC (LOS ALAMOS, New Mexico);  KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (MANHATTAN, Kansas)
ASSIGNEE(S)
INVENTOR(S) Aida E. Rieder (WESTBROOK, Connecticut);  KATHERINE M. PFLAUM (MIDDLETOWN, Connecticut);  FAYNA C. DIAZ SAN SEGUNDO (BLUE POINT, New York);  WILLIAM M. FISCHER (LOS ALAMOS, New Mexico);  TATJANA SITT (ESSEX, Connecticut)
ABSTRACT Synthetic foot-and-mouth disease virus (FMDV) mosaic polypeptides, and nucleic acid molecules encoding the mosaic polypeptides, are described. When included as part of an FMDV genome, the mosaic polypeptides permit virus replication and assembly into FMDV particles. The mosaic polypeptide and nucleic acid compositions can be used to elicit immune responses that provide protection against a broad range of serotype O FMDV strains.
FILED Wednesday, August 17, 2022
APPL NO 17/889737
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/135 (20130101) Original (OR) Class
A61K 2039/552 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149877 Cummings et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) Honeywell Federal Manufacturing & Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing & Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Laura Christine Cummings (Kansas City, Missouri);  Eric Benjamin Cole (Lee's Summit, Missouri);  Connor Daniel Pearson (Overland Park, Kansas)
ABSTRACT An apparatus, methods, and systems for forming microspheres comprises a furnace and an ultrasonic nozzle. The furnace has a channel and is operable to generate heat in the channel. The ultrasonic nozzle is configured to receive precursor solution and spray precursor droplets into the channel so that the heat in the channel causes the precursor droplets to form the microspheres.
FILED Tuesday, November 15, 2022
APPL NO 17/987654
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 13/04 (20130101) Original (OR) Class

Spraying Apparatus; Atomising Apparatus; Nozzles
B05B 17/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149912 TAIT, JR. et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana)
ASSIGNEE(S)
INVENTOR(S) Steven L. TAIT, JR. (Bloomington, Indiana);  Iyad Syed ALI (Chesterton, Indiana);  Linxiao CHEN (Issaquah, Washington)
ABSTRACT The invention describes metal catalysts such as Pt single-site centers on metal oxide supports, e.g., powdered supports, such as MgO, Al2O3, CeO2 or mixtures thereof with phenyl or biphenyl ligands substituted with two or more carboxylic acid groups.
FILED Thursday, April 29, 2021
APPL NO 17/921012
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 23/10 (20130101)
B01J 31/26 (20130101)
B01J 31/1815 (20130101)
B01J 31/2239 (20130101) Original (OR) Class
B01J 2231/323 (20130101)
B01J 2531/828 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/1876 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150007 Reyes
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) Honeywell Federal Manufacturing & Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S) Honeywell Federal Manufacturing & Technologies, LLC (Kansas City, Missouri)
INVENTOR(S) Joseph Reyes (Gladstone, Missouri)
ABSTRACT A tool for handling a die assembly, the tool including a rocker and a swivel. The rocker includes a foot and a backrest. The foot engages a base of the die assembly when the tool is upright and stabilizes the die assembly as the tool is leaned from being upright to reclined. The backrest extends vertically from the foot when the tool is upright. The swivel supports an outer shell and other components of the die assembly on the backrest and translates and rotates relative to the backrest when the tool is reclined to rotate the outer shell and other components from an inverted orientation to a non-inverted orientation. The foot stabilizes the die as the tool is leaned from being reclined to upright and can be moved horizontally out of engagement with the base when the tool is upright.
FILED Tuesday, November 16, 2021
APPL NO 17/527793
CURRENT CPC
Working or Processing of Sheet Metal or Metal Tubes, Rods or Profiles Without Essentially Removing Material; Punching Metal
B21D 37/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150021 Tappan et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Triad National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) Triad National Security, LLC (Los Alamos, New Mexico)
INVENTOR(S) Bryce Tappan (Santa Fe, New Mexico);  Andrew Schmalzer (Los Alamos, New Mexico);  Alexander H. MUELLER (Santa Fe, New Mexico)
ABSTRACT Processes for tailoring the macroscopic shape, metallic composition, mechanical properties, and pore structure of nanoporous metal foams prepared through combustion synthesis via direct write 3D printing of metal energetic ligand precursor inks made with water and an organic thickening agent are disclosed. Such processes enable production of never before obtainable metal structures with hierarchical porosity, tailorable from the millimeter size regime to the nanometer size regime. Structures produced by these processes have numerous applications including, but not limited to, catalysts, heat exchangers, low density structural materials, biomedical implants, hydrogen storage medium, fuel cells, and batteries.
FILED Tuesday, January 17, 2023
APPL NO 18/098035
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/1121 (20130101) Original (OR) Class
B22F 10/00 (20210101)
B22F 10/60 (20210101)
B22F 2998/00 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 11/52 (20130101)

Alloys
C22C 1/08 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 1/092 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150022 Whalen et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Pacific Northwest National Laboratory (PNNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Battelle Memorial Institute (BMI) at Richland, WA
APPLICANT(S) Battelle Memorial Institute (Richland, Washington)
ASSIGNEE(S)
INVENTOR(S) Scott A. Whalen (West Richland, Washington);  Jens T. Darsell (West Richland, Washington);  MD. Reza-E-Rabby (Richland, Washington);  Brandon Scott Taysom (West Richland, Washington);  Tianhao Wang (Richland, Washington);  Darrell R. Herling (Kennewick, Washington);  Xiao Li (Richland, Washington)
ABSTRACT A method for preparing a shear-assisted extruded material from a powder billet is provided, the method comprising providing a billet of material in substantially powder form; applying both axial and rotational pressure to the material to deform at least some of the contacted material; and extruding the material to form an extruded material. A method for preparing shear-assisted extruded material is provided, the method comprising applying both axial and rotational pressure to stock material to form an extruded material at a rate between 2 and 13 m/min. A method for preparing shear-assisted extruded material is provided. The method comprises applying both axial and rotational pressure to stock material to form an extruded material; and aging the extruded material for less than 3 hours. A method for preparing shear-assisted extruded material is provided. The method comprises providing a stock material for shear-assisted extrusion; and applying both axial and rotational force to the stock material to form an extruded material, wherein the axial force does not decrease during the extrusion.
FILED Thursday, January 05, 2023
APPL NO 18/093636
CURRENT CPC
Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/20 (20130101) Original (OR) Class
B22F 3/24 (20130101)
B22F 2003/248 (20130101)
B22F 2301/052 (20130101)
B22F 2302/25 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150502 Dickson et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Cummins Inc. (Columbus, Indiana)
ASSIGNEE(S) Cummins Inc. (Columbus, Indiana)
INVENTOR(S) Jonathan A. Dickson (Columbus, Indiana);  Kenneth M. Follen (Greenwood, Indiana);  Arun Prakash Thunga Gopal (Columbus, Indiana);  J. Steven Kolhouse (Columbus, Indiana);  Manik Narula (Columbus, Indiana);  Apurva Arvind Chunodkar (Greenwood, Indiana)
ABSTRACT Systems, methods, and apparatuses for improving predictive cruise control and predictive engine off coasting for a vehicle are provided. An apparatus includes one or more processing circuits having one or more memory devices coupled to one or more processors, the one or more memory devices configured to store instructions thereon that, when executed by the one or more processors, cause the one or more processors to: receive look ahead information and store the look ahead information in the one or more memory devices; receive vehicle information regarding operation of a vehicle including an engine; determine a coasting opportunity for the vehicle based on the look ahead information and the vehicle information; modulate a cruise control set speed based on the determined coasting opportunity; and turn the engine off during the determined coasting opportunity for the vehicle based on modulation of the cruise control set speed.
FILED Thursday, November 10, 2022
APPL NO 17/984735
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 30/143 (20130101)
B60W 30/18072 (20130101) Original (OR) Class
B60W 50/14 (20130101)
B60W 2030/1809 (20130101)
B60W 2510/06 (20130101)
B60W 2510/10 (20130101)
B60W 2510/30 (20130101)
B60W 2552/15 (20200201)
B60W 2554/00 (20200201)
B60W 2554/802 (20200201)
B60W 2555/20 (20200201)
B60W 2555/60 (20200201)
B60W 2710/1005 (20130101)
B60W 2720/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150821 Gailus
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Nanocomp Technologies Inc. (The Woodlands, Texas)
ASSIGNEE(S)
INVENTOR(S) David Gailus (Merrick, New Hampshire)
ABSTRACT The present disclosure provides a method for producing elongated non-entangled nanotube filaments using a vertical upward flow floating catalyst chemical vapor deposition system.
FILED Tuesday, April 06, 2021
APPL NO 17/916860
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 32/162 (20170801) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151031 Luo et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Tianyi Luo (Baltimore, Maryland);  Michael Tsapatsis (Baltimore, Maryland);  Zhiyong Xia (Baltimore, Maryland)
ABSTRACT The present disclosure relates to modified metal-organic frameworks (MOFs) and a post-synthetic modification method that simultaneously enhances hydrophilicity and water stability to achieve high-performance water sorption materials.
FILED Monday, November 14, 2022
APPL NO 18/054956
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151033 Even
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Kansas City National Security Campus (KCNSC)
NNSA Critical Mission Site
Operated by Honeywell Federal Manufacturing and Technologies, LLC (FM&T) at Kansas City, MO
APPLICANT(S) Honeywell Federal Manufacturing and Technologies, LLC (Kansas City, Missouri)
ASSIGNEE(S)
INVENTOR(S) Dakota Even (Overland Park, Kansas)
ABSTRACT A method for forming monosubstituted diphenylsilanes is broadly provided. The method involves reacting diphenylsilane with an alcohol in the presence of a catalyst and a strong base activator. The reaction results in high selectivity to addition at only one hydrogen site.
FILED Wednesday, November 17, 2021
APPL NO 17/528747
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/2273 (20130101)
B01J 2531/16 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/0874 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151340 BECKHAM et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado);  University of Portsmouth (Portsmouth, United Kingdom)
ASSIGNEE(S)
INVENTOR(S) Gregg Tyler BECKHAM (Golden, Colorado);  Erika Marie ERICKSON (Berkeley, California);  John E. MCGEEHAN (Portsmouth, United Kingdom)
ABSTRACT The present disclosure relates to a non-naturally occurring enzyme that includes a first polypeptide that catalyzes the hydrolysis of a polyester to produce mono-(2-hydroxyethyl) terephthalate (MHET), a second polypeptide that catalyzes the cleavage of MHET to produce at least one of terephthalic acid or ethylene glycol, and a third polypeptide that links the first polypeptide with the second polypeptide.
FILED Monday, May 10, 2021
APPL NO 17/921833
CURRENT CPC
Disposal of Solid Waste
B09B 3/60 (20220101)
B09B 2101/75 (20220101)

Peptides
C07K 2319/00 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 11/105 (20130101)
C08J 2367/02 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/18 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151450 Codd et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) Daniel S. Codd (San Diego, California);  Joseph J. McCrink (Carlsbad, California)
ASSIGNEE(S)
INVENTOR(S) Daniel S. Codd (San Diego, California);  Joseph J. McCrink (Carlsbad, California)
ABSTRACT An integrated welding and thermal processing method includes heating adjoining surfaces, at least one of which is a creep strength enhanced ferritic (CSEF) steel alloy, to a sufficiently high temperature above their melting points to form a weld. The weld is allowed cool below the martensitic start temperature of one or both CSEF alloys. Thereafter, a supplemental heat source tempers the CSEF alloys by reheating the weld area at a rate of 10° C. per second or greater to above the CSEF alloys’ martensitic start temperatures, but not above the austenitization temperature of the CSEF alloys. After the weld’s heat affected zone is maintained at a temperature between the CSEF alloys’ martensitic finish temperature and martensitic start temperature, the weld is allowed to cool at a rate of 15° C. per minute or greater.
FILED Tuesday, November 15, 2022
APPL NO 17/987484
CURRENT CPC
Soldering or Unsoldering; Welding; Cladding or Plating by Soldering or Welding; Cutting by Applying Heat Locally, e.g Flame Cutting; Working by Laser Beam
B23K 31/027 (20130101)

Modifying the Physical Structure of Ferrous Metals; General Devices for Heat Treatment of Ferrous or Non-ferrous Metals or Alloys; Making Metal Malleable, e.g by Decarburisation or Tempering
C21D 1/42 (20130101)
C21D 6/002 (20130101)
C21D 6/005 (20130101)
C21D 9/08 (20130101) Original (OR) Class
C21D 2211/008 (20130101)

Alloys
C22C 38/001 (20130101)
C22C 38/04 (20130101)
C22C 38/22 (20130101)
C22C 38/24 (20130101)
C22C 38/26 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151499 Feaster et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Jeremy Taylor Feaster (Fremont, California);  Roger D. Aines (Livermore, California);  Sneha Anil Akhade (Oakland, California);  Sarah E. Baker (Dublin, California);  Patrick G. Campbell (Oakland, California);  Maira R. Cerón Hernández (Brentwood, California);  Jonathan Tesner Davis (Oakland, California);  Eric B. Duoss (Dublin, California)
ASSIGNEE(S)
INVENTOR(S) Jeremy Taylor Feaster (Fremont, California);  Roger D. Aines (Livermore, California);  Sneha Anil Akhade (Oakland, California);  Sarah E. Baker (Dublin, California);  Patrick G. Campbell (Oakland, California);  Maira R. Cerón Hernández (Brentwood, California);  Jonathan Tesner Davis (Oakland, California);  Eric B. Duoss (Dublin, California)
ABSTRACT An advanced manufactured electrochemical reactor to convert air (N2+O2) to nitric acid (HNO3) and ammonia (NH3). The electrochemical reactor platform can be tailored via advanced manufacturing to improve activity, selectivity, energy efficiency and stability of the reactions.
FILED Thursday, November 03, 2022
APPL NO 18/052310
CURRENT CPC
Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 1/22 (20130101)
C25B 1/27 (20210101) Original (OR) Class
C25B 11/077 (20210101)
C25B 11/081 (20210101)
C25B 11/089 (20210101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151868 Bird
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Portland State University (Portland, Oregon)
ASSIGNEE(S) Portland State University (Portland, Oregon)
INVENTOR(S) Jonathan Bird (Portland, Oregon)
ABSTRACT Various examples of a variable stiffness magnetic spring with a linear stroke length are provided. The stiffness of the magnetic springs is varied through rotation of one or more magnets, and both positive and negative spring constants are achievable. In one example, a variable stiffness magnetic spring includes a first magnetic component and a second magnetic component, wherein the first magnetic component is coaxial with the second magnetic component, the first magnetic component is rotatable about an axis and relative to the second magnetic component to adjust a stiffness of the variable stiffness magnetic spring, and the second magnetic component is translatable along the axis and relative to the first magnetic component. While such variable stiffness magnetic springs exhibit highly linear stroke lengths, such variable stiffness magnetic springs can be positioned in series to achieve an even longer linear stroke length.
FILED Friday, October 14, 2022
APPL NO 17/966734
CURRENT CPC
Springs; Shock-absorbers; Means for Damping Vibration
F16F 6/005 (20130101) Original (OR) Class
F16F 2222/06 (20130101)
F16F 2228/066 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152090 MUKHERJEE et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Saptarshi MUKHERJEE (Milpitas, California);  Tammy CHANG (San Ramon, California)
ABSTRACT The present disclosure relates to a system for detecting and analyzing droplets of feedstock material being ejected from an additive manufacturing device. The system makes use of a split ring resonator (SRR) probe including a ring element having a gap, with the gap being positioned adjacent a path of travel of the droplets of feedstock material. An excitation signal source is used for supplying an excitation signal to the SRR probe. An analyzer analyzes signals generated by the SRR probe in response to perturbations in an electric field generated by the SRR probe as the droplets of feedstock material pass the ring element. The signals are indicative of dimensions of the droplets of feedstock material.
FILED Thursday, November 18, 2021
APPL NO 17/455549
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 40/00 (20141201)

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 15/00 (20130101)
G01B 21/12 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 22/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152362 Tilles
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Julia Napolin Tilles (Albuquerque, New Mexico)
ABSTRACT An interferometric radioimager provides real-time, high-fidelity radioimaging of high voltage breakdown (HVB) both internal and external to electrical components at sub-nanosecond and sub-millimeter resolution and has an ability to resolve multiple/spatially-extensive HVB simultaneously. Therefore, radioimaging can be used to screen for early life weakness/failure and enable non-destructive screening of defective electrical components. In particular, radioimaging can detect precursors to catastrophic HVB, allowing for early detection of weakness in critical electrical components. Radioimaging can also be used to track HVB and pinpoint defects in electrical components real time, including transformers, capacitors, cables, switches, and microelectronics.
FILED Friday, November 18, 2022
APPL NO 17/990405
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 29/12 (20130101)
G01R 31/1218 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153676 Freedman et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOE-SC)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The University of Chicago (Chicago, Illinois);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Danna E. Freedman (Evanston, Illinois);  David D. Awschalom (Chicago, Illinois);  Dan W. Laorenza (Evanston, Illinois);  Majed S. Fataftah (New Haven, Connecticut);  Sam L. Bayliss (Chicago, Illinois);  Berk Diler (Chicago, Illinois);  Peter J. Mintun (Chicago, Illinois)
ABSTRACT A molecular-spin qubit is formed from a coordination complex having a plurality of strong-field ligands bound to a metal-atom center. The ground state has non-zero spin, and the resulting ground-state magnetic sublevels are separated by microwave or millimeter-wave frequencies, even in the absence of an external field. Two of these sublevels may be used as a quantum resource for quantum information processing, quantum communication, quantum memory, sensing, and other applications. Optical pumping to an excited state may be used to spin-polarize the molecular-spin qubit, and to measure its population by detecting photoluminescence. The energy-level structure of the metal-atom center can be modified due to its interaction with the ligands, therefore allowing the molecular-spin qubit to be “chemically tuned” based on the number and type of ligands. Ensembles of these molecular-spin qubits can be controllably deposited on a surface, or otherwise integrated into devices and structures.
FILED Friday, April 09, 2021
APPL NO 17/995825
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/13 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/2208 (20130101)
C07F 11/00 (20130101)

Computer Systems Based on Specific Computational Models
G06N 10/40 (20220101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153699 Chen et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) TRIAD National Security, LLC. (Los Alamos, New Mexico)
ASSIGNEE(S)
INVENTOR(S) Yue Chen (Los Alamos, New Mexico);  Youzuo Lin (Los Alamos, New Mexico);  Rafael Pires de Lima (Los Alamos, New Mexico);  Saurabh Sinha (Los Alamos, New Mexico)
ABSTRACT A method includes receiving a plurality of data sets, wherein the plurality of data sets includes a measured low-energy electrons that is less than or equal to 1.5 MeV, and wherein the plurality of data sets further includes data associated with solar wind. The method further includes receiving measured data associated with higher electron events of greater than or equal to 2 MeV In response to a selection of at least two data sets from the plurality of data sets, and further in response to a selection of one or more machine learning (ML) algorithms from a plurality of ML algorithms, and further in response to a selection of a number of window size, a plurality of ML models is generated based on the selections as an input and the measured data associated with higher electron events of greater than or equal to 2 MeV as its output.
FILED Tuesday, October 12, 2021
APPL NO 17/499591
CURRENT CPC
Measurement of Nuclear or X-radiation
G01T 5/00 (20130101)

Computer Systems Based on Specific Computational Models
G06N 20/20 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154555 RAASCH et al.
FUNDED BY
Department of Energy (DOE)
Exascale Computing Project (ECP)
PathForward Project (PATHFORWARD)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) ADVANCED MICRO DEVICES, INC. (SANTA CLARA, California)
ASSIGNEE(S)
INVENTOR(S) STEVEN RAASCH (BOXBOROUGH, Massachusetts);  GREG SADOWSKI (BOXBOROUGH, Massachusetts);  DAVID A. ROBERTS (BOXBOROUGH, Massachusetts)
ABSTRACT Exemplary embodiments provide wear spreading among die regions (i.e., one or more circuits) in an integrated circuit or among dies by using operating condition data in addition to or instead of environmental data such as temperature data, from each of a plurality of die regions. Control logic produces a cumulative amount of time each of the plurality of die regions has spent at an operating condition based on operating condition data wherein the operating condition data is based on at least one of the following operating characteristics: frequency of operation of the plurality of die regions, an operating voltage of the plurality of die regions, an activity level of the plurality of die regions, a timing margin of the plurality of die regions, and a number of detected faults of the plurality of die regions. The method and apparatus spreads wear among the plurality of same type of die regions by controlling task execution among the plurality of die regions using the die wear-out data.
FILED Friday, January 13, 2023
APPL NO 18/154372
CURRENT CPC
Electric Digital Data Processing
G06F 3/064 (20130101)
G06F 3/0616 (20130101)
G06F 3/0679 (20130101)
G06F 9/50 (20130101)
G06F 12/0223 (20130101)
G06F 12/0246 (20130101)
G06F 2212/1036 (20130101)
G06F 2212/7211 (20130101)

Static Stores
G11C 7/04 (20130101)
G11C 11/4076 (20130101)
G11C 16/349 (20130101)
G11C 16/3418 (20130101)
G11C 16/3495 (20130101) Original (OR) Class
G11C 29/70 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154561 Cheng et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
APPLICANT(S) The Curators of the University of Missouri (Columbia, Missouri)
ASSIGNEE(S)
INVENTOR(S) Jianlin Cheng (Columbia, Missouri);  Elham Soltanikazemi (Columbia, Missouri);  Raj Shekhor Roy (Columbia, Missouri);  Farhan Quadir (Columbia, Missouri)
ABSTRACT Deep learning systems and methods for predicting structural aspects of protein-related complexes are described herein. An example method for predicting inter-chain distances of protein-related complexes includes receiving data associated with a protein-related complex, where the data associated with the protein-related complex includes at least one of a tertiary structural feature and a multiple sequence alignment (MSA)-derived feature. The method also includes inputting the data associated with the protein-related complex into a deep learning model. The method further includes predicting, using the deep learning model, an inter-chain distance map for the protein-related complex.
FILED Wednesday, November 16, 2022
APPL NO 17/988461
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101)
G06N 3/045 (20230101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 15/20 (20190201)
G16B 15/30 (20190201) Original (OR) Class
G16B 40/00 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154635 ARNDT et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) Westinghouse Electric Company LLC (Cranberry Township, Pennsylvania)
ASSIGNEE(S) Westinghouse Electric Company LLC (Cranberry Township, Pennsylvania)
INVENTOR(S) Jeffrey L. ARNDT (Pittsburgh, Pennsylvania);  Paolo FERRONI (Pittsburgh, Pennsylvania);  Cory A. STANSBURY (Gorham, Maine)
ABSTRACT A non-invasive eddy current flow meter embedded into a coolant channel for measuring the coolant flow velocity of liquid metal coolant in a nuclear reactor. The eddy current flow meter measures the coolant flow velocity in pool-type nuclear reactors and narrow coolant channels without creating bottlenecks that impede the coolant flow within the nuclear reactors.
FILED Monday, November 15, 2021
APPL NO 17/454920
CURRENT CPC
Measuring Volume, Volume Flow, Mass Flow or Liquid Level; Metering by Volume
G01F 1/588 (20130101)

Nuclear Reactors
G21C 17/032 (20130101) Original (OR) Class

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 9/0081 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155153 Huo et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Twelve Benefit Corporation (Berkeley, California)
ASSIGNEE(S)
INVENTOR(S) Ziyang Huo (Moraga, California);  Chengtian Shen (Irvine, California);  Kenneth X. Hau (San Jose, California);  Angelica L. Reyes (Berkeley, California)
ABSTRACT Aspects of this disclosure pertain to catalyst compositions that include electrically conductive support particles; and metal catalyst particles attached to the electrically conductive support particles. The catalyst compositions may be used in cathodes of carbon oxide reduction electrolyzers.
FILED Wednesday, November 09, 2022
APPL NO 18/053945
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/926 (20130101)
H01M 4/8673 (20130101)
H01M 4/9041 (20130101)
H01M 4/9083 (20130101)
H01M 8/1004 (20130101) Original (OR) Class
H01M 2250/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155155 Song et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) ESS TECH, INC. (Wilsonville, Oregon)
ASSIGNEE(S)
INVENTOR(S) Yang Song (West Linn, Oregon);  Kenneth Kiyoshi Fisher (Porland, Oregon);  Timothy McDonald (Portland, Oregon)
ABSTRACT Methods and systems are provided for transporting and hydrating a redox flow battery system with a portable field hydration system. In one example, the redox flow battery system may be hydrated with the portable field hydration system in a dry state, in the absence of liquids. In this way, a redox flow battery system may be assembled and transported from a battery manufacturing facility to an end-use location off-site while the redox flow battery system is in the dry state, thereby reducing shipping costs, design complexities, as well as logistical and environmental concerns.
FILED Thursday, January 05, 2023
APPL NO 18/150751
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/86 (20130101)
H01M 8/188 (20130101) Original (OR) Class
H01M 8/04119 (20130101)
H01M 8/04225 (20160201)
H01M 8/04283 (20130101)
H01M 50/60 (20210101)
H01M 2004/8684 (20130101)
H01M 2004/8689 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155175 Zhu et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Wildcat Discovery Technologies, Inc. (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Ye Zhu (San Diego, California);  Gang Cheng (San Diego, California);  Deidre Strand (San Diego, California);  Jen-Hsien Yang (San Diego, California)
ABSTRACT Additives to electrolytes that enable the formation of comparatively more robust SEI films on silicon-based anodes. The SEI films in these embodiments are seen to be more robust in part because the batteries containing these materials have higher coulombic efficiency and longer cycle life than comparable batteries without such additives. The additives preferably contain a dicarbonate group or are an organo-metallic hydride.
FILED Thursday, July 21, 2022
APPL NO 17/870460
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/131 (20130101)
H01M 4/134 (20130101)
H01M 4/386 (20130101)
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 10/0525 (20130101)
H01M 10/0567 (20130101) Original (OR) Class
H01M 2004/027 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155384 Chinthavali et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Madhu Sudhan Chinthavali (Oak Ridge, Tennessee);  Michael Starke (Oak Ridge, Tennessee);  Radha Krishna Moorthy (Oak Ridge, Tennessee);  Steven Campbell (Oak Ridge, Tennessee)
ABSTRACT A hierarchical approach is provided to integrate functions and components into the various systems and subsystems within a distribution network, including standardization of modular and scalable power electronics power blocks with embedded diagnostics and prognostics.
FILED Thursday, November 17, 2022
APPL NO 17/989373
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 1/14 (20130101)
H02J 1/084 (20200101)
H02J 3/16 (20130101) Original (OR) Class
H02J 3/381 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155389 Chinthavali et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Madhu Sudhan Chinthavali (Oak Ridge, Tennessee);  Michael Starke (Oak Ridge, Tennessee);  Radha Krishna Moorthy (Oak Ridge, Tennessee);  Steven Campbell (Oak Ridge, Tennessee)
ABSTRACT A hierarchical approach is provided to integrate functions and components into the various systems and subsystems within a distribution network, including standardization of modular and scalable power electronics power blocks with embedded diagnostics and prognostics.
FILED Thursday, November 17, 2022
APPL NO 17/989376
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/06 (20130101)
H02J 3/16 (20130101)
H02J 3/381 (20130101) Original (OR) Class
H02J 2203/20 (20200101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155390 Chinthavali et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S)
INVENTOR(S) Madhu Sudhan Chinthavali (Oak Ridge, Tennessee);  Michael Starke (Oak Ridge, Tennessee);  Radha Krishna Moorthy (Oak Ridge, Tennessee);  Steven Campbell (Oak Ridge, Tennessee)
ABSTRACT A hierarchical approach is provided to integrate functions and components into the various systems and subsystems within a distribution network, including standardization of modular and scalable power electronics power blocks with embedded diagnostics and prognostics.
FILED Thursday, November 17, 2022
APPL NO 17/989379
CURRENT CPC
Boards, Substations, or Switching Arrangements for the Supply or Distribution of Electric Power
H02B 1/00 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/381 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230156380 McDonald et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (Spring, Texas)
ASSIGNEE(S)
INVENTOR(S) Nicholas McDonald (Fort Collins, Colorado);  Gary Gostin (Plano, Texas);  Alan Davis (Palo Alto, California)
ABSTRACT A system for hot swapping a network switch without disconnecting the network switch connectors is provided. The system disaggregates the switch faceplate network cable connectors from the internal components of the network switch so that the internal switch components may be removed from the switch without disconnecting the switch network cables.
FILED Friday, January 13, 2023
APPL NO 18/154580
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 49/15 (20130101)
H04L 49/30 (20130101)
H04L 49/45 (20130101)

Selecting
H04Q 11/0005 (20130101) Original (OR) Class
H04Q 2011/0041 (20130101)
H04Q 2011/0052 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230157039 ZHU et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
ASSIGNEE(S)
INVENTOR(S) Kai ZHU (Littleton, Colorado);  Jinhui TONG (Golden, Colorado);  Qi JIANG (Lakewood, Colorado)
ABSTRACT The present disclosure relates to a composition that includes a perovskite phase having the stoichiometry ABX3 and a perovskite-like phase having the stoichiometry A′2A″B′2X′, where A is a first cation, B is a second cation, X is a first anion, A′ is a third cation, A″ is a fourth cation, B′ is a fifth cation, X′ is a second anion, and A′ is different than A″.
FILED Friday, July 22, 2022
APPL NO 17/814433
CURRENT CPC
Organic electric solid-state devices
H10K 30/57 (20230201) Original (OR) Class
H10K 85/50 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 20230149216 Knox et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) University of Rochester (Rochester, New York)
ASSIGNEE(S)
INVENTOR(S) Wayne Knox (Rochester, New York);  Jonathan D. Ellis (Tucson, Arizona);  Krystel R. Huxlin (Rush, New York);  Daniel R. Brooks (Rochester, New York);  Kaitlin T. Wozniak (Rochester, New York)
ABSTRACT Refractive index writing system and methods employing a pulsed laser source for providing a pulsed laser output at a first wavelength; an objective lens for focusing the pulsed laser output to a focal spot in an optical material; a scanner for relatively moving the focal spot with respect to the optical material at a relative speed and direction along a scan region for writing one or more traces in the optical material defined by a change in refractive index; and a controller for controlling laser exposures along the one or more traces in accordance with a calibration function for the optical material to achieve a desired refractive index profile in the optical material. The refractive index writing system may be for writing traces in in vivo optical tissue, and the controller may be configured with a calibration function obtained by calibrating refractive index change induced in enucleated ocular globes. A real-time process control monitor for detecting emissions from the optical material transmitted through the objective lens at a second wavelength may further be employed while writing the one or more traces.
FILED Friday, January 20, 2023
APPL NO 18/099402
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 9/00804 (20130101)
A61F 9/00827 (20130101) Original (OR) Class
A61F 2009/00855 (20130101)
A61F 2009/00897 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149620 Turer et al.
FUNDED BY
National Science Foundation (NSF)
Directorate of Technology, Innovation and Partnerships (TIP)
Translational Impacts (TI)
APPLICANT(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  UPMC (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh - Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  UPMC (Pittsburgh, Pennsylvania)
INVENTOR(S) David Turer (Pittsburgh, Pennsylvania);  William W. Clark (Wexford, Pennsylvania);  April Lawrence (Pittsburgh, Pennsylvania);  Ehsan Qaium (Pittsburgh, Pennsylvania);  Joseph P. Rubin (Pittsburgh, Pennsylvania);  Cameron Dezfulian (Pittsburgh, Pennsylvania)
ABSTRACT Disclosed cannula systems can detect the tissue type within which the cannula tip is located in real time using electrodes adjacent the cannula tip. The sensing cannula system can differentiate when the cannula tip is in adipose tissue or muscle based on electrical impedance. The system can be used in fat grafting and liposuction procedures, for example. An operator can detect if the cannula tip enters muscle by watching for an indicator light or audible alarm that is automatically activated by the device based on a change in sensed impedance. The device may also stop the flow of fat through a pump halting injection into the sub-muscular space.
FILED Tuesday, January 03, 2023
APPL NO 18/149394
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 1/73 (20210501)
A61M 1/743 (20210501) Original (OR) Class
A61M 2202/08 (20130101)
A61M 2205/581 (20130101)
A61M 2205/584 (20130101)
A61M 2205/587 (20130101)
A61M 2205/3584 (20130101)
A61M 2230/65 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149832 Menkhaus et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) NANOPAREIL, LLC (Dakota Dunes, South Dakota)
ASSIGNEE(S)
INVENTOR(S) Todd J. Menkhaus (Dakota Dunes, South Dakota);  Steven Schneiderman (Dakota Dunes, South Dakota)
ABSTRACT The present disclosure provides surface functionalized affinity membranes. The surface functionalized affinity membranes can provide increased binding capacity through improved coupling chemistries, ligand densities, spacer arm types, and spacer arm lengths. Methods of preparing the surface functionalized affinity membranes and methods of using the surface functionalized affinity membranes to isolate targets of interest, including nucleic acid molecules and proteins, from a sample are also provided.
FILED Friday, September 30, 2022
APPL NO 17/937251
CURRENT CPC
Separation
B01D 15/3828 (20130101) Original (OR) Class
B01D 67/0002 (20130101)
B01D 67/00931 (20220801)
B01D 69/02 (20130101)
B01D 69/144 (20130101)
B01D 69/1071 (20220801)
B01D 2323/36 (20130101)
B01D 2325/12 (20130101)
B01D 2325/36 (20130101)
B01D 2325/38 (20130101)
B01D 2325/42 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/3255 (20130101)
B01J 20/3274 (20130101)
B01J 20/28038 (20130101)
B01J 2220/54 (20130101)
B01J 2220/80 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/54353 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149923 Hui et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Elliot En-Yu Hui (Irvine, California);  Hinesh Vipul Patel (Irvine, California)
ABSTRACT The present invention is directed to the fabrication and use of phase-change material (PCM) membranes in microvalves for microfluidic systems. The microvalve may be fabricated by using a tissue-sectioning instrument to slice a thin membrane of PCM off of a block of PCM. The membrane may then be sandwiched between a plurality of microfluidic flow sections to act as a microvalve. At room temperature, the membrane may exist in a solid state to act as a zero-leakage seal and microvalve. Applying heat to the membrane may bring the membrane to a melting point, causing it to reach a liquid state. The microvalve in the liquid state may experience a surface tension effect by a material of the microfluidic flow sections, causing it to displace from a flow path and allow a fluid to pass from one microfluidic flow section to another.
FILED Friday, April 09, 2021
APPL NO 17/995842
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50273 (20130101)
B01L 3/502715 (20130101) Original (OR) Class
B01L 3/502738 (20130101)
B01L 2200/0689 (20130101)
B01L 2300/0861 (20130101)
B01L 2400/0677 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150192 Sant et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California);  Technical University of Munich (Munich, Germany);  Master Builders Construction Chemicals (Beachwood, Ohio)
ASSIGNEE(S)
INVENTOR(S) Gaurav Sant (Los Angeles, California);  Sharu Bhagavathi Kandy (Los Angeles, California);  Torben Gädt (Traunstein, Germany);  Iman Mehdipour (Los Angeles, California);  Thiyagarajan Ranganathan (Los Angeles, California);  Samanvaya Srivastava (Los Angeles, California);  Paul Seiler (Aurora, Ohio)
ABSTRACT A thermoresponsive suspension composition for use in additive manufacturing includes an aqueous suspension of a thermosetting resin, a crosslinking agent configured to react with the thermosetting resin, and a mineral particulate, wherein the thermosetting resin and crosslinking agent react at or above a trigger temperature.
FILED Thursday, November 18, 2021
APPL NO 17/529763
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/165 (20170801) Original (OR) Class

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
B33Y 70/00 (20141201)
B33Y 80/00 (20141201)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 59/245 (20130101)
C08G 59/4064 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 3/26 (20130101)
C08K 3/36 (20130101)
C08K 5/3445 (20130101)
C08K 2003/265 (20130101)

Compositions of Macromolecular Compounds
C08L 63/00 (20130101)
C08L 2201/54 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230150943 Goodson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Board of Trustees of Southern Illinois University (Carbondale, Illinois);  Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Boyd M. Goodson (Carbondale, Illinois);  Eduard Y. Chekmenev (Troy, Michigan);  Bryce E. Kidd (Carbondale, Illinois);  Jamil A. Mashni (Carbondale, Illinois);  Miranda Limbach (Creal Springs, Illinois);  Yuqing Hou (Carbondale, Illinois);  Fan Shi (Houston, Texas)
ABSTRACT The present disclosure is directed to a cleavable agent for enhanced magnetic resonance generally corresponding to the formula Y-L-R, wherein Y represents a catalyst-binding moiety having at least one isotopically labeled heteroatom, L represents a cleavable bond, and R represents a hyperpolarized payload having at least one isotopically labeled carbon. Also disclosed herein is a method of cleaving the cleavable agent for enhanced magnetic resonance.
FILED Wednesday, January 04, 2023
APPL NO 18/149740
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 31/12 (20130101)
B01J 2531/827 (20130101)

Heterocyclic Compounds
C07D 213/46 (20130101)
C07D 213/63 (20130101)
C07D 233/60 (20130101) Original (OR) Class
C07D 241/12 (20130101)
C07D 401/06 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/6506 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/46 (20130101)
G01R 33/282 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151062 FOX et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of Colorado, a Body Corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Jerome FOX (Boulder, Colorado);  Ankur SARKAR (Boulder, Colorado);  Akarawin HONGDUSIT (Boulder, Colorado);  Edward KIM (Oakland, California)
ABSTRACT This invention relates to the field of genetic engineering. Specifically, the invention relates to the construction of operons to produce biologically active agents. For example, operons may be constructed to produce agents that control the function of biochemical pathway proteins (e.g., protein phosphatases, kinases and/or proteases). Such agents may include inhibitors and modulators that may be used in studying or controlling phosphatase function associated with abnormalities in a phosphatase pathway or expression level. Fusion proteins, such as light activated protein phosphatases, may be genetically encoded and expressed as photoswitchable phosphatases. Systems are provided for use in controlling phosphatase function within living cells or in identifying small molecule inhibitors/activator/modulator molecules of protein phosphatases associated with cell signaling.
FILED Tuesday, August 02, 2022
APPL NO 17/816937
CURRENT CPC
Peptides
C07K 14/005 (20130101) Original (OR) Class
C07K 14/47 (20130101)
C07K 2319/80 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/20 (20130101)

Enzymes
C12Y 205/0101 (20130101)
C12Y 205/01001 (20130101)
C12Y 207/01036 (20130101)
C12Y 207/04002 (20130101)
C12Y 301/01048 (20130101)
C12Y 401/01033 (20130101)
C12Y 402/03017 (20130101)
C12Y 402/03018 (20130101)
C12Y 402/03024 (20130101)
C12Y 402/03056 (20130101)
C12Y 503/03002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151128 CABANERO et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S)
INVENTOR(S) DAVID C. CABANERO (New York, New York);  TOMISLAV ROVIS (New York, New York)
ABSTRACT Exemplary methods, catalysts, catalyst compositions and systems are provided to activate a latent ruthenium olefin metathesis catalyst using a deep red to near infrared light (e.g., 600-800 nm) in conjunction with an osmium (II) photocatalyst that is directly excited to its triplet state via spin-forbidden excitation. An excited state single electron reduction of a latent solvent coordinated, cationic pre-catalyst is proposed as the operating mechanism for activation and photocontrol, as probed via in situ LED NMR kinetic studies and cyclic voltammetry. Excellent levels of spatiotemporal control can be found under light irradiation. NIR olefin metathesis exhibits improved light penetration through barriers over lower wavelengths of light, a control element that was deployed to mold dicyclopentadiene via Ring Opening Metathesis Polymerization (ROMP).
FILED Monday, October 31, 2022
APPL NO 17/977146
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 2/46 (20130101)
C08F 4/80 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151211 Hallinan, Jr. et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Florida State University Research Foundation, Inc. (Tallahassee, Florida);  The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Daniel Hallinan, Jr. (Tallahassee, Florida);  Justin G. Kennemur (Tallahassee, Florida);  Karen I. Winey (Philadelphia, Pennsylvania);  Benjamin A. Paren (Philadelphia, Pennsylvania);  Kyoungmin Kim (Sandy, Utah);  Michael Patrick Blatt (Tallahassee, Florida)
ABSTRACT Polymer blends that may be used as electrolytes. Devices that include polymer blends. Methods of forming polymer blends. The polymer blends may include a polysolvent and a polymer, such as a polymer that includes a negatively charged sidechain. The devices may include a lithium ion battery.
FILED Thursday, November 17, 2022
APPL NO 18/056562
CURRENT CPC
Compositions of Macromolecular Compounds
C08L 71/02 (20130101) Original (OR) Class

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 10/0525 (20130101)
H01M 10/0565 (20130101)
H01M 2300/0082 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151354 FOX et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of Colorado, a Body Corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Jerome FOX (Boulder, Colorado);  Ankur SARKAR (Boulder, Colorado)
ABSTRACT The disclosure provides systems, methods, reagents, apparatuses, vectors, and host cells for the discovery and evolution of metabolic pathways that produce small molecules that modulate enzyme function.
FILED Thursday, July 07, 2022
APPL NO 17/859509
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/88 (20130101)
C12N 15/52 (20130101)
C12N 15/70 (20130101)
C12N 15/1055 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 5/007 (20130101)

Enzymes
C12Y 205/01029 (20130101)
C12Y 402/03017 (20130101)
C12Y 402/03018 (20130101)
C12Y 402/03038 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151405 WANG et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) THE PENN STATE RESEARCH FOUNDATION (University Park, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Yong WANG (State College, Pennsylvania);  Brandon J. DAVIS (State College, Pennsylvania);  Peng SHI (State College, Pennsylvania)
ABSTRACT The present invention provides methods for signal amplification. The methods use DNA hybridization chain reaction to build labeled nanoscaffolds off of target analytes. The methods are reversible, as the detectable signal can be removed using DNA hybridization and hydrolysis.
FILED Thursday, April 15, 2021
APPL NO 17/919225
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6804 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/582 (20130101)
G01N 33/5308 (20130101)
G01N 2458/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151576 FROST et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) GEORGIA TECH RESEARCH CORPORATION (Atlanta, Georgia)
ASSIGNEE(S)
INVENTOR(S) James David FROST (Atlanta, Georgia);  John A. HUNTOON (Atlanta, Georgia);  Seth D. MALLETT (Atlanta, Georgia)
ABSTRACT Various implementations include a ground anchoring apparatus including a longitudinal body, first and second retaining members, and a set of expanding linkage assemblies. The first retaining member is rigidly coupled to the longitudinal body. The second retaining member is movably coupled to the longitudinal body. Each expanding linkage assembly includes first and second linkage members. The first linkage member has first and second portions, and the second linkage member has third and fourth portions. The first portion is rotatably coupled to the first retaining member. The fourth portion is rotatably coupled to the second retaining member. The third portion is rotatably coupled to the second portion. The set of expanding linkage assemblies is movable between a collapsed and expanded configuration. The second retaining member is closer to the first retaining member and the third portion is further from the central axis in the expanded configuration than in the collapsed configuration.
FILED Friday, April 02, 2021
APPL NO 17/915900
CURRENT CPC
Foundations; Excavations; Embankments; Underground or Underwater Structures
E02D 5/803 (20130101) Original (OR) Class
E02D 2600/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152230 FAN et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Xudong FAN (Ann Arbor, Michigan);  Qiushu CHEN (San Bruno, California);  Yunlu SUN (Ann Arbor, Michigan)
ABSTRACT The present disclosure provides an imaging system. The imaging system may include a laser cavity that is configured to receive a biological sample, where the biological sample is treated with a dye; an excitation light source that is configured to direct energy at the laser cavity so as to cause an emission from the biological sample, where the emission includes a laser emission at a first spectral band and a fluorescence emission at a second spectral band; a first detector that is configured to measure the laser emission generated by the biological sample; a second detector that is configured to measure the fluorescence emission generated by the biological sample; a splitter that is configured to direct the laser emission to the first detector and the fluorescence emission to the second detector; and a controller interfaced with the excitation light source, the first detector, and the second detector.
FILED Friday, April 30, 2021
APPL NO 17/919671
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6428 (20130101)
G01N 21/6458 (20130101) Original (OR) Class
G01N 2021/6421 (20130101)
G01N 2021/6439 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152329 Ghosh et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona)
ASSIGNEE(S)
INVENTOR(S) Indraneel Ghosh (Tucson, Arizona);  Matthew Bienick (Tucson, Arizona);  Sean Campbell (Bronx, New York);  Carl Buchholz (Roanoke, Virginia)
ABSTRACT A method to produce novel split-protein sensors are described herein. The method implements a sequence dissimilarity (SD) based design that can identify potential split-sites in proteins to generate a split-protein pair, and then employs structure guided mutagenesis of the fragmented protein interface to generate split-protein sensors. The sensors have a signal to background ratio >200 and can be readily used to monitor protein-protein interactions and their inhibition in cells.
FILED Monday, March 08, 2021
APPL NO 17/905675
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/66 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6845 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152672 Bidwell et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Circle Optics, Inc. (Rochester, New York)
ASSIGNEE(S)
INVENTOR(S) Thomas Bidwell (Bergen, New York);  Christopher M. Muir (Rochester, New York);  Eugene Sisto (Rochester, New York);  Andrew F. Kurtz (Macedon, New York);  Allen Krisiloff (Rochester, New York);  John Bowron (Burlington, Canada);  Zakariya Niazi (Rochester, New York);  Robert Stanchus (Wolcott, New York);  James Mazzarella (Fairport, New York);  Robert Baldino (Spencerport, New York);  Deanan DaSilva (Playa del Rey, California);  Jose Manuel Sasian-Alva (Tucson, Arizona);  Charles E. Brugger (Webster, New York)
ABSTRACT A low parallax imaging device includes a plurality of imaging lens elements arranged to capture adjacent fields of view. In some examples, adjacent imaging lens elements may contact at datum features to maintain a desired spacing. The spacing may allow for partial overlapping of low-parallax volumes associated with the respective imaging lens elements.
FILED Tuesday, December 22, 2020
APPL NO 17/908158
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 7/14 (20130101)
G02B 13/06 (20130101)
G02B 27/0025 (20130101)

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 17/14 (20130101) Original (OR) Class
G03B 17/561 (20130101)
G03B 37/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153287 Stephens et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) AirMettle, Inc. (Houston, Texas)
ASSIGNEE(S)
INVENTOR(S) Donpaul C. Stephens (Houston, Texas);  Joshua R. Fuhs (Columbus, Indiana)
ABSTRACT A technique of partitioning compressed data includes splitting the compressed data into multiple portions. The technique further includes storing a decompression state in association with a current portion, wherein the decompression state is based on data of a previous portion and enables decompression of the current portion independently of other portions.
FILED Tuesday, November 01, 2022
APPL NO 17/978609
CURRENT CPC
Electric Digital Data Processing
G06F 16/278 (20190101)
G06F 16/1744 (20190101)
G06F 16/2282 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153676 Freedman et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOE-SC)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) The University of Chicago (Chicago, Illinois);  Northwestern University (Evanston, Illinois)
ASSIGNEE(S)
INVENTOR(S) Danna E. Freedman (Evanston, Illinois);  David D. Awschalom (Chicago, Illinois);  Dan W. Laorenza (Evanston, Illinois);  Majed S. Fataftah (New Haven, Connecticut);  Sam L. Bayliss (Chicago, Illinois);  Berk Diler (Chicago, Illinois);  Peter J. Mintun (Chicago, Illinois)
ABSTRACT A molecular-spin qubit is formed from a coordination complex having a plurality of strong-field ligands bound to a metal-atom center. The ground state has non-zero spin, and the resulting ground-state magnetic sublevels are separated by microwave or millimeter-wave frequencies, even in the absence of an external field. Two of these sublevels may be used as a quantum resource for quantum information processing, quantum communication, quantum memory, sensing, and other applications. Optical pumping to an excited state may be used to spin-polarize the molecular-spin qubit, and to measure its population by detecting photoluminescence. The energy-level structure of the metal-atom center can be modified due to its interaction with the ligands, therefore allowing the molecular-spin qubit to be “chemically tuned” based on the number and type of ligands. Ensembles of these molecular-spin qubits can be controllably deposited on a surface, or otherwise integrated into devices and structures.
FILED Friday, April 09, 2021
APPL NO 17/995825
CURRENT CPC
General Methods of Organic Chemistry; Apparatus Therefor
C07B 2200/13 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/2208 (20130101)
C07F 11/00 (20130101)

Computer Systems Based on Specific Computational Models
G06N 10/40 (20220101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230153692 Hong et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota);  Oregon State University (Corvallis, Oregon)
ASSIGNEE(S)
INVENTOR(S) Mingyi Hong (Wayzata, Minnesota);  Haoran Sun (Bellevue, Washington);  Xiao Fu (Albany, Oregon)
ABSTRACT A wireless communication system includes memory configured to store a model for predicting one or more parameters of the system, and one or more processors configured to: receive samples of the wireless communication system over a plurality of sequential batches, each of the batches represents a different, non-overlapping period of time; for each of the batches: select, based on a sample selection criteria, a subset of the samples from a first batch as representative samples for the first batch, wherein the sample selection criteria is based on a system performance metric computed for each of the samples; store the subset of the samples for one or more of the sequential batches in the memory; and upon receiving samples for a second batch, train the model to predict the one or more parameters using the samples from the second batch and the subset of the samples stored in the memory.
FILED Thursday, November 10, 2022
APPL NO 18/054479
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 20/00 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154178 Krista
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of Colorado, a body corporate (Denver, Colorado)
ASSIGNEE(S)
INVENTOR(S) Larisza D. Krista (Erie, Colorado)
ABSTRACT A system for forecasting when solar flares will occur and identifying their possible locations creates a mask to analyze an image of a solar disk. The system also creates an intensity histogram using the solar disk. Additionally, the system stores a resulting full-disk image and a sub-image identifying possible flare signature sites. Further, the system applies a method to filter out false positive detections by using an equation that enhances true positive pre-flare signatures and minimizes false positive signatures.
FILED Friday, November 11, 2022
APPL NO 17/985727
CURRENT CPC
Image or Video Recognition or Understanding
G06V 10/22 (20220101)
G06V 10/36 (20220101)
G06V 20/13 (20220101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154465 KELLY et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (PITTSBURGH, Pennsylvania);  THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate (DENVER, Colorado)
ASSIGNEE(S) UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (PITTSBURGH, Pennsylvania);  THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate (DENVER, Colorado)
INVENTOR(S) SEAN P. KELLY (PITTSBURGH, Pennsylvania);  SIDNEY D'MELLO (BOULDER, Colorado)
ABSTRACT A method of analyzing instructor discourse includes recording an audio signal representing speech of the instructor during a class session, converting the audio signal to a session transcript comprising speech data for the session using an automatic speech recognition tool and segmenting the transcript into utterances, extracting a set of features from the session transcript, filtering student talk out from the utterances, analyzing a first subset of the features to produce a number of local context predictions for each utterance of the session transcript, analyzing a second subset of the features to produce a number of global context predictions for the session transcript, and combining a subset of the number of local context predictions and the number of global context predictions into a classification that attends to differential reliability.
FILED Wednesday, April 14, 2021
APPL NO 17/917429
CURRENT CPC
Speech Analysis or Synthesis; Speech Recognition; Speech or Voice Processing; Speech or Audio Coding or Decoding
G10L 15/01 (20130101)
G10L 15/26 (20130101) Original (OR) Class
G10L 21/0272 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154561 Cheng et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
APPLICANT(S) The Curators of the University of Missouri (Columbia, Missouri)
ASSIGNEE(S)
INVENTOR(S) Jianlin Cheng (Columbia, Missouri);  Elham Soltanikazemi (Columbia, Missouri);  Raj Shekhor Roy (Columbia, Missouri);  Farhan Quadir (Columbia, Missouri)
ABSTRACT Deep learning systems and methods for predicting structural aspects of protein-related complexes are described herein. An example method for predicting inter-chain distances of protein-related complexes includes receiving data associated with a protein-related complex, where the data associated with the protein-related complex includes at least one of a tertiary structural feature and a multiple sequence alignment (MSA)-derived feature. The method also includes inputting the data associated with the protein-related complex into a deep learning model. The method further includes predicting, using the deep learning model, an inter-chain distance map for the protein-related complex.
FILED Wednesday, November 16, 2022
APPL NO 17/988461
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 3/08 (20130101)
G06N 3/045 (20230101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 15/20 (20190201)
G16B 15/30 (20190201) Original (OR) Class
G16B 40/00 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154641 Watkins et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) University of Massachusetts (Boston, Massachusetts)
ASSIGNEE(S) University of Massachusetts (Boston, Massachusetts)
INVENTOR(S) James Watkins (South Hadley, Massachusetts);  Michael R. Beaulieu (Chicopee, Massachusetts);  Nicholas R. Hendricks (South Deerfield, Massachusetts)
ABSTRACT Aspects relate to patterned nanostructures having a feature size not including film thickness of below 5 microns. The patterned nanostructures are made up of nanoparticles having an average particle size of less than 100 nm. A nanoparticle composition, which, in some cases, includes a binder, is applied to a substrate. A patterned mold used in concert with electromagnetic radiation function to manipulate the nanoparticle composition in forming the patterned nanostructure. In some embodiments, the patterned mold nanoimprints a pattern onto the nanoparticle composition and the composition is cured through UV or thermal energy. Three-dimensional patterned nanostructures may be formed. A number of patterned nanostructure layers may be prepared and joined together. In some cases, a patterned nanostructure may be formed as a layer that is releasable from the substrate upon which it is initially formed. Such releasable layers may be arranged to form a three-dimensional patterned nanostructure for suitable applications.
FILED Thursday, January 19, 2023
APPL NO 18/098804
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Optical Elements, Systems, or Apparatus
G02B 1/118 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/08 (20130101) Original (OR) Class
H01B 3/10 (20130101)
H01B 13/003 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/04 (20130101)
H01M 6/40 (20130101)
H01M 8/124 (20130101)

Organic electric solid-state devices
H10K 71/211 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154736 Jarrold et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana)
ASSIGNEE(S)
INVENTOR(S) Martin F. Jarrold (Bloomington, Indiana);  Andrew W. Alexander (Bloomington, Indiana);  Aaron R. Todd (Bloomington, Indiana)
ABSTRACT A CDMS may include an ion source to generate ions from a sample, a mass spectrometer to separate the generated ions as a function of ion mass-to-charge ratio, an electrostatic linear ion trap (ELIT) having a charge detection cylinder disposed between first and second ion mirrors, wherein ions exiting the mass spectrometer are supplied to the ELIT, a charge generator for generating free charges, a field free region between the charge generator and the charge detection cylinder, and a processor configured to control the charge generator, with no ions in the charge detection cylinder, to generate a target number of free charges and cause the target number of free charges to travel across the field-free region and into contact with the charge detection cylinder to deposit the target number of free charges thereon and thereby calibrate or reset the charge detection cylinder to a corresponding target charge level.
FILED Wednesday, January 04, 2023
APPL NO 18/149743
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 49/0009 (20130101)
H01J 49/022 (20130101)
H01J 49/025 (20130101) Original (OR) Class
H01J 49/4245 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230154741 JARROLD et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Indiana)
ASSIGNEE(S)
INVENTOR(S) Martin F. JARROLD (Bloomington, Indiana);  Daniel BOTAMANENKO (Bloomington, Indiana)
ABSTRACT A charge detection mass spectrometer may include an ion source to generate ions, a mass spectrometer to separate the generated ions as a function of ion mass-to-charge ratio to produce beam of separated ions, an electrostatic linear ion trap (ELIT) including a charge detection cylinder disposed between a pair of coaxially aligned ion mirrors, and means for controlling a trajectory of the beam of separated ions entering the ELIT to cause the ions subsequently trapped in the ELIT to oscillate therein with different planar ion oscillation trajectories angularly offset from one another about the longitudinal axis with each extending along and crossing the longitudinal axis in each of the ion mirrors or with different cylindrical ion oscillation trajectories radially offset from one another about the longitudinal axis to form nested cylindrical trajectories each extending along the longitudinal axis.
FILED Tuesday, December 27, 2022
APPL NO 18/146768
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/623 (20210101)

Electric Discharge Tubes or Discharge Lamps
H01J 49/022 (20130101)
H01J 49/025 (20130101)
H01J 49/426 (20130101)
H01J 49/482 (20130101)
H01J 49/4245 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155090 VISELL et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S)
INVENTOR(S) Yon VISELL (Goleta, California);  Shantonu BISWAS (Santa Barbara, California)
ABSTRACT A method of manufacturing a stretchable electronic device includes the steps of: a) depositing a release layer on a temporary rigid substrate; b) depositing a sacrificial layer on the release layer; c) fabricating conductive traces and electrical contacts on top of the sacrificial layer; d) mounting surface mount components (SMCs) to the electrical contacts; e) depositing a first stretchable polymer layer over the conductive traces and SMCs to form a stretchable substrate; f) separating the rigid substrate and release layer from the sacrificial layer and the stretchable substrate at an interface between the release layer and the sacrificial layer; g) removing the sacrificial layer from the stretchable substrate; and h) depositing a second stretchable polymer layer on a surface of the stretchable substrate exposed by removing the sacrificial layer.
FILED Friday, May 07, 2021
APPL NO 17/798325
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 25/167 (20130101)
H01L 33/005 (20130101)
H01L 33/44 (20130101)
H01L 33/62 (20130101) Original (OR) Class
H01L 2933/0025 (20130101)
H01L 2933/0066 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155136 Smith
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, Illinois)
INVENTOR(S) Kyle Christopher Smith (Champaign, Illinois)
ABSTRACT Aspects of the subject disclosure may include, for example, a porous device, comprising a porous material, and a hierarchical network of flow channels defined in the porous material, wherein at least one flow channel in the hierarchical network of flow channels has a shape that at least partially approximates a cube-root profile or a quartic-root profile. Additional embodiments are disclosed.
FILED Thursday, November 03, 2022
APPL NO 17/980023
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 80/00 (20141201)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/8626 (20130101) Original (OR) Class
H01M 4/8878 (20130101)
H01M 8/0258 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155371 Mysore et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Pratap Gopal Mysore (Plymouth, Minnesota);  Daniel Kelly (St. Paul, Minnesota);  Ned Mohan (St. Paul, Minnesota)
ABSTRACT A method is provided for operating an inverter of an inverter-based power resource providing electric power to a grid through one or more transformers. The method includes measuring voltages associated with terminals on a selected primary winding and/or measuring voltages associated with terminals on a selected secondary winding; and injecting currents into the primary terminals of the selected primary winding during a fault condition based on the measured voltages being indicative of the type of fault occurring. Preferably the inverter is operated to emulate at least some characteristics of fault currents provided by a generator having rotating magnets or electrical windings. An apparatus is configured to operate in accordance with the method and includes an electrical switching device circuit having input terminals for an inverter-based power resource and output terminals for providing AC electric power to an electric power grid. An inverter controller operates the electrical switching device circuit.
FILED Wednesday, March 24, 2021
APPL NO 17/917112
CURRENT CPC
Emergency Protective Circuit Arrangements
H02H 3/40 (20130101)

Apparatus for Conversion Between AC and AC, Between AC and DC, or Between DC and DC, and for Use With Mains or Similar Power Supply Systems; Conversion of DC or AC Input Power into Surge Output Power; Control or Regulation Thereof
H02M 7/539 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230157144 LIN et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) University of Washington (Seattle, Washington)
ASSIGNEE(S)
INVENTOR(S) Lih-Yuan LIN (Seattle, Washington);  Chen ZOU (Seattle, Washington);  Ethan G. KEELER (Seattle, Washington)
ABSTRACT A method includes forming a barrier layer on a substrate, removing a portion of the barrier layer to yield a patterned barrier layer and an exposed portion of the substrate within a hole in the patterned barrier layer, forming a first portion of a perovskite on the patterned barrier layer and a second portion of the perovskite on the exposed portion of the substrate, and removing the patterned barrier layer, thereby removing the first portion of the perovskite.
FILED Thursday, April 01, 2021
APPL NO 17/915819
CURRENT CPC
Organic electric solid-state devices
H10K 59/35 (20230201)
H10K 71/15 (20230201)
H10K 71/211 (20230201) Original (OR) Class
H10K 85/50 (20230201)
H10K 85/111 (20230201)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 20230149146 GIORDANO et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) CORNELL UNIVERSITY (Ithaca, New York)
ASSIGNEE(S)
INVENTOR(S) Julio GIORDANO (Ithaca, New York);  David ERICKSON (Ithaca, New York);  Yue REN (Ithaca, New York);  Magdalena Masello SOUZA (Washington, District of Columbia)
ABSTRACT An automated controlled device for livestock management and methods of use thereof. The device includes a housing configured to be inserted into a body cavity. One or more reservoirs are configured to be located within the housing and to store a fluid. One or more pumps are coupled to the one or more reservoirs. The one or more pumps are configured to deliver fluid stored in the one or more reservoirs to an area external to the housing during use. A microcontroller is coupled to the one or more pumps. The microcontroller is configured to operate the one or more pumps to deliver a predetermined volume of the fluid stored in the one or more reservoirs to the area external to the housing at a scheduled time
FILED Tuesday, April 27, 2021
APPL NO 17/920475
CURRENT CPC
Veterinary Instruments, Implements, Tools, or Methods
A61D 19/022 (20130101)
A61D 19/027 (20130101) Original (OR) Class

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 2205/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149528 Rieder et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  Triad National Security, LLC (LOS ALAMOS, New Mexico);  KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (MANHATTAN, Kansas)
ASSIGNEE(S)
INVENTOR(S) Aida E. Rieder (WESTBROOK, Connecticut);  KATHERINE M. PFLAUM (MIDDLETOWN, Connecticut);  FAYNA C. DIAZ SAN SEGUNDO (BLUE POINT, New York);  WILLIAM M. FISCHER (LOS ALAMOS, New Mexico);  TATJANA SITT (ESSEX, Connecticut)
ABSTRACT Synthetic foot-and-mouth disease virus (FMDV) mosaic polypeptides, and nucleic acid molecules encoding the mosaic polypeptides, are described. When included as part of an FMDV genome, the mosaic polypeptides permit virus replication and assembly into FMDV particles. The mosaic polypeptide and nucleic acid compositions can be used to elicit immune responses that provide protection against a broad range of serotype O FMDV strains.
FILED Wednesday, August 17, 2022
APPL NO 17/889737
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/135 (20130101) Original (OR) Class
A61K 2039/552 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152232 KIM et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S)
INVENTOR(S) MOON S. KIM (ASHTON, Maryland);  JIANWEI QIN (ELLICOTT CITY, Maryland);  DIANE E. CHAN (ODENTON, Maryland);  LYNDEL MEINHARDT (COLLEGE PARK, Maryland);  INSUCK BAEK (BURTONSVILLE, Maryland);  KENNETH BARTON (PALM CITY, Florida);  FARTASH VASEFI (SHERMAN OAKS, California)
ABSTRACT The contamination sanitation inspection system (CSIS) allows a user to capture an image of a large scene (such as a food processing line, a food service facility, a food products storage area, or a plant production area/facility) and identify contamination within the scene and preferably represent the contamination on a spatially accurate map (or floorplan) so that contamination within the inspection map area is clearly identified and recorded for subsequent treatment. In an alternative embodiment, the CSIS also includes a decontamination system to sanitize any identified contamination.
FILED Wednesday, November 17, 2021
APPL NO 17/529019
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 2/10 (20130101)
A61L 2/28 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/94 (20130101)
G01N 21/6486 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 20230149248 Walker et al.
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) Case Western Reserve University (Cleveland, Ohio)
ASSIGNEE(S)
INVENTOR(S) Mark Walker (Shaker Heights, Ohio);  Michael Fu (Mayfield Heights, Ohio)
ABSTRACT Methods and systems for dynamically prescribing therapeutic games for treatment of ocular disorder are disclosed. The methods and systems include: performing an eye position calibration technique in a virtual reality environment to calibrate the virtual reality environment to a user; performing an eye movement measurement to produce a diagnosis result; selecting a virtual reality therapeutic game based on the diagnosis result; performing the virtual reality therapeutic game to receive a game user input in the virtual reality therapeutic game; and dynamically adjusting difficulty of the virtual reality therapeutic game based on the game user input. Other aspects, embodiments, and features are also claimed and described.
FILED Wednesday, November 16, 2022
APPL NO 18/056249
CURRENT CPC
Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 5/00 (20130101) Original (OR) Class
A61H 5/005 (20130101)
A61H 2201/1604 (20130101)
A61H 2201/5007 (20130101)
A61H 2201/5043 (20130101)
A61H 2230/00 (20130101)

Card, Board, or Roulette Games; Indoor Games Using Small Moving Playing Bodies; Video Games; Games Not Otherwise Provided for
A63F 13/67 (20140902)
A63F 13/213 (20140902)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230149469 Frank et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The United States Government as represented by The Department of Veterans Affairs (Washington, District of Columbia);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) The United States Government as represented by The Department of Veterans Affairs (Washington, District of Columbia);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  Children's Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) Markus H. Frank (Cambridge, Massachusetts);  Natasha Y. Frank (Cambridge, Massachusetts);  Dennis P. Orgill (Belmont, Massachusetts);  George F. Murphy (Boston, Massachusetts)
ABSTRACT The present invention is directed to wound healing scaffolds cografted with a population of stem cells, wherein the population of stem cells are ABCB5+ stem cells. The scaffolds are, for instance, collagen glycosaminoglycan scaffolds.
FILED Monday, September 19, 2022
APPL NO 17/947360
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101) Original (OR) Class
A61K 38/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/3834 (20130101)
A61L 27/3886 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/063 (20130101)
C12N 5/0668 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230151071 Sathyanesan et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia);  UNIVERSITY OF SOUTH DAKOTA (Vermillion, South Dakota)
ASSIGNEE(S)
INVENTOR(S) Samuel Newton Sathyanesan (Vermillion, South Dakota);  Monica Sathyanesan (Vermillion, South Dakota);  Jason Petersen (Washington, District of Columbia)
ABSTRACT Disclosed are polypeptides comprising an engineered recombinant EPO. For example, disclosed are polypeptides comprising the sequence of SEQ ID NO: 1. Disclosed are variant Epo polypeptides comprising three amino acid substitutions at positions 20, 45 and 97 of wild type human Epo. Disclosed are polynucleotides comprising a nucleic acid capable of encoding one or more of the disclosed polypeptides. Disclosed are vectors comprising any of the polynucleotides disclosed herein. Disclosed are compositions comprising the disclosed polypeptides, polynucleotides or vectors. Disclosed are cells comprising one or more of the disclosed polypeptides, one or more of the disclosed polynucleotides, and/or one or more of the disclosed vectors. Disclosed are methods of using a therapeutically effective amount of one or more of the disclosed polypeptides, nucleic acids or vectors to a subject in need thereof.
FILED Friday, April 09, 2021
APPL NO 17/917264
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 25/28 (20180101)

Peptides
C07K 14/505 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 20230150663 McCall et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) ATA, LLC (Vienna, Virginia)
ASSIGNEE(S)
INVENTOR(S) Micaela McCall (Albuquerque, New Mexico);  Boris Boiko (Baltimore, Maryland);  Matthew Scott Drew (Alexandria, Virginia);  John S. Eberhardt, III (Vienna, Virginia);  Mitchell Horning (Reston, Virginia);  James Hughes (Austin, Texas);  Eric Kucks (Annandale, Virginia);  Cameron Peterson (Logan, Utah);  Zack Radeka (Reston, Virginia);  Emily Richards (St. Charles, Missouri)
ABSTRACT A method includes receiving a first navigation path risk request that includes first navigation path information associated with a first navigation path for a first unmanned vehicle through a first environment. The method also includes selecting a first risk model from a plurality of risk models based on the first navigation path information. The method also includes obtaining first data used as one or more inputs to run the first risk model from one or more data sources. The method also includes operating the first risk model with the first data to output a first risk score. The method also includes providing a first navigation path risk response in response to the first navigation path risk request that includes the first risk score that is associated with at least a portion of the first navigation path.
FILED Monday, September 19, 2022
APPL NO 17/947549
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101) Original (OR) Class
B64C 2201/145 (20130101)

Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230152008 Brewer et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) Blueshift, LLC dba Outward Technologies (Broomfield, Colorado)
ASSIGNEE(S) Blueshift, LLC dba Outward Technologies (Broomfield, Colorado)
INVENTOR(S) Andrew Timon Brewer (Wheat Ridge, Colorado);  Ryan Garvey (Lafayette, Colorado);  Alan Thomas Carter (Arvada, Colorado);  Austin Kenneth Miller (Niwot, Colorado);  Troy Southard (Edgewater, Colorado)
ABSTRACT A solar energy particle receiver system and method of use for precise and controlled heating, sintering, and/or phase change of particles. In one embodiment, the solar energy particle receiver system directs sunlight from a primary concentrator into supplemental concentrating reflective optic where the emitted sunlight is used to heat and sinter, melt, or induce a phase change of the particles such as regolith at a controlled temperature, the supplemental concentrating reflective optics cooled to prevent overheating and a sweeping gas directed at the reflective surface to prevent optical fouling. In one aspect, the supplemental concentrating reflective optic is a compound reflective concentrator. In one application, the particles are a regolith, such as a lunar regolith.
FILED Tuesday, November 08, 2022
APPL NO 17/983266
CURRENT CPC
Solar Heat Collectors; Solar Heat Systems
F24S 23/71 (20180501)
F24S 40/55 (20180501)
F24S 50/80 (20180501) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155545 Bolisay et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) L'Garde, Inc. (Tustin, California)
ASSIGNEE(S)
INVENTOR(S) Linden Bolisay (Las Vegas, Nevada);  Arthur Palisoc (Tustin, California)
ABSTRACT Exemplary embodiments described herein may include lightweight, low stow volume solar concentrator.
FILED Thursday, September 01, 2022
APPL NO 17/929275
CURRENT CPC
Cosmonautics; Vehicles or Equipment Therefor
B64G 99/00 (20220801)

Generation of Electric Power by Conversion of Infra-red Radiation, Visible Light or Ultraviolet Light, e.g Using Photovoltaic [PV] Modules
H02S 40/22 (20141201) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 20230149528 Rieder et al.
FUNDED BY
Department of Homeland Security (DHS)
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  Triad National Security, LLC (LOS ALAMOS, New Mexico);  KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (MANHATTAN, Kansas)
ASSIGNEE(S)
INVENTOR(S) Aida E. Rieder (WESTBROOK, Connecticut);  KATHERINE M. PFLAUM (MIDDLETOWN, Connecticut);  FAYNA C. DIAZ SAN SEGUNDO (BLUE POINT, New York);  WILLIAM M. FISCHER (LOS ALAMOS, New Mexico);  TATJANA SITT (ESSEX, Connecticut)
ABSTRACT Synthetic foot-and-mouth disease virus (FMDV) mosaic polypeptides, and nucleic acid molecules encoding the mosaic polypeptides, are described. When included as part of an FMDV genome, the mosaic polypeptides permit virus replication and assembly into FMDV particles. The mosaic polypeptide and nucleic acid compositions can be used to elicit immune responses that provide protection against a broad range of serotype O FMDV strains.
FILED Wednesday, August 17, 2022
APPL NO 17/889737
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/135 (20130101) Original (OR) Class
A61K 2039/552 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/14 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230156465 Boyd et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Daniel A. Boyd (Arlington, Virginia);  Kelli L. Biegger (Fort Worth, Texas);  Chang Ellison (Arlington, Virginia);  Brandon P. Gutierrez (Johns Creek, Georgia);  Jason Lim (Alexandria, Virginia);  William Washington (North Potomac, Maryland)
ABSTRACT A vehicle information remote retrieval method includes an emergency personnel or first responder vehicle (FRV) establishing a vehicle connection between an infotainment system of a vehicle and the FRV. The FRV sends a vehicle information request to the infotainment system of the vehicle, via the vehicle connection, seeking release of vehicle information. The FRV obtains authentication of the vehicle information received in response to the vehicle information request. The FRV determines occupant status based on the vehicle information. The FRV communicates the passenger status to a first responder.
FILED Monday, January 23, 2023
APPL NO 18/100040
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 7/10 (20130101)

Wireless Communication Networks
H04W 4/46 (20180201)
H04W 12/02 (20130101)
H04W 12/04 (20130101) Original (OR) Class
H04W 12/08 (20130101)
H04W 12/033 (20210101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 20230150663 McCall et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) ATA, LLC (Vienna, Virginia)
ASSIGNEE(S)
INVENTOR(S) Micaela McCall (Albuquerque, New Mexico);  Boris Boiko (Baltimore, Maryland);  Matthew Scott Drew (Alexandria, Virginia);  John S. Eberhardt, III (Vienna, Virginia);  Mitchell Horning (Reston, Virginia);  James Hughes (Austin, Texas);  Eric Kucks (Annandale, Virginia);  Cameron Peterson (Logan, Utah);  Zack Radeka (Reston, Virginia);  Emily Richards (St. Charles, Missouri)
ABSTRACT A method includes receiving a first navigation path risk request that includes first navigation path information associated with a first navigation path for a first unmanned vehicle through a first environment. The method also includes selecting a first risk model from a plurality of risk models based on the first navigation path information. The method also includes obtaining first data used as one or more inputs to run the first risk model from one or more data sources. The method also includes operating the first risk model with the first data to output a first risk score. The method also includes providing a first navigation path risk response in response to the first navigation path risk request that includes the first risk score that is associated with at least a portion of the first navigation path.
FILED Monday, September 19, 2022
APPL NO 17/947549
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101) Original (OR) Class
B64C 2201/145 (20130101)

Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 20230155168 Lin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Bioenno Tech LLC (Santa Ana, California)
ASSIGNEE(S)
INVENTOR(S) Zhigang Lin (Santa Ana, California);  Chunhu Tan (Santa Ana, California);  Tianyu Meng (Santa Ana, California)
ABSTRACT Electrolyte-infiltrated composite electrode includes an electrolyte component consisting of a polymer matrix with ceramic nanoparticles embedded in the matrix to form a networking structure of electrolyte. Suitable ceramic nanoparticles have the basic formula Li7La3Zr2O12 (LLZO) and its derivatives such as AlxLi7-xLa3Zr2-y-zTayNbzO12 where x ranges from 0 to 0.85, y ranges from 0 to 0.50 and z ranges from 0 to 0.75, wherein at least one of x, y and z is not equal to 0. The networking structure of the electrolyte establishes an effective lithium-ion transport pathway in the electrode and strengthens the contact between electrode layer and solid-state electrolyte resulting in higher lithium-ion electrochemical cell's cycling stability and longer battery life. Sold-state electrolytes incorporating the ceramic particles demonstrate improved performance. Large dimensional electrolyte-infiltrated composite electrode sheets can be used in all solid-state lithium electrochemical pouch cells which can be assembled into battery packs.
FILED Monday, January 16, 2023
APPL NO 18/097384
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/505 (20130101)
H01M 4/525 (20130101)
H01M 4/622 (20130101)
H01M 4/625 (20130101)
H01M 10/0525 (20130101)
H01M 10/0562 (20130101) Original (OR) Class
H01M 2004/021 (20130101)
H01M 2300/0071 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of the Interior (DOI) 

US 20230149855 Sirkar et al.
FUNDED BY
Department of the Interior (DOI)
Bureau of Reclamation (USBR)
APPLICANT(S) New Jersey Institute of Technology (Newark, New Jersey);  Applied Membrane Technology, Inc. (Minnetonka, Minnesota)
ASSIGNEE(S)
INVENTOR(S) Kamalesh Sirkar (Bridgewater, New Jersey);  Dhananjay Singh (Kearny, New Jersey);  Lin Li (Kearny, New Jersey);  Thomas J. McEvoy (Tofte, Minnesota)
ABSTRACT Exemplary embodiments in desalination by direct contact membrane distillation present a cylindrical cross-flow module containing high-flux composite hydrophobic hollow fiber membranes. The present embodiments are directed to a model that has been developed to describe the observed water production rates of such devices in multiple brine feed introduction configurations. The model describes the observed water vapor production rates for different feed brine temperatures at various feed brine flow rates. The model flux predictions have been explored over a range of hollow fiber lengths to compare the present results with those obtained earlier from rectangular modules which had significantly shorter hollow fibers.
FILED Wednesday, December 21, 2022
APPL NO 18/085724
CURRENT CPC
Separation
B01D 61/364 (20130101)
B01D 61/366 (20130101) Original (OR) Class
B01D 63/04 (20130101)
B01D 2313/10 (20130101)
B01D 2313/12 (20130101)
B01D 2313/21 (20130101)
B01D 2315/10 (20130101)
B01D 2325/38 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/447 (20130101)
C02F 2103/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

How To Use This Page 

THE FEDINVENT PATENT APPLICATION DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Thursday, May 18, 2023.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week's taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer-funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract is presented as it appears on the patent.

FILED
The date the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that the more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2022/fedinvent-applications-20230518.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital